{"gene":"HSPB1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1992,"finding":"MAPKAP kinase-2 (MK2) is the major kinase responsible for phosphorylating small mammalian heat shock proteins, phosphorylating Ser15 and Ser86 of murine Hsp25 and Ser15, Ser78, and Ser82 of human Hsp27 in response to growth factors and heat shock.","method":"In vitro kinase assay, co-purification, peptide substrate mapping","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with site-specific phosphorylation mapping, foundational paper with >498 citations, independently confirmed","pmids":["1332886"],"is_preprint":false},{"year":1993,"finding":"Murine Hsp25 and human Hsp27 function as ATP-independent molecular chaperones, preventing aggregation of unfolding proteins (citrate synthase, alpha-glucosidase) under heat shock conditions and promoting their refolding after urea denaturation.","method":"In vitro chaperone assay with purified proteins, thermal aggregation and refolding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with multiple substrates, foundational paper >1000 citations","pmids":["8093612"],"is_preprint":false},{"year":1995,"finding":"Phosphorylation of HSP27 by MAPKAP kinase reduces its large oligomeric size and is required for actin filament stabilization; phosphorylated HSP27 protects microfilaments from heat-induced disruption and accelerates actin recovery, while a non-phosphorylatable mutant (HSP27-pm3) fails to provide these protective effects.","method":"Stable transfection of wild-type and phosphorylation-site mutant HSP27 in Chinese hamster cells; cytochalasin D treatment; heat shock survival; immunofluorescence of actin","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with phosphomutants plus multiple functional readouts, >568 citations, replicated","pmids":["7799959"],"is_preprint":false},{"year":1999,"finding":"Phosphorylation of Hsp27/Hsp25 at Ser15, Ser78, Ser82 (mimicked by S15D/S78D/S82D triple mutant) causes dissociation of large oligomers to tetramers, significantly decreases chaperone activity in thermal denaturation and refolding assays, and abolishes protection against oxidative stress when overexpressed in cells.","method":"In vitro phosphorylation, phosphomimetic mutagenesis, gel filtration, thermal aggregation assay, cell survival assays in L929 and 13.S.1.24 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution + mutagenesis + cell-based functional assays, >626 citations","pmids":["10383393"],"is_preprint":false},{"year":2000,"finding":"Hsp27 inhibits the mitochondrial apoptotic pathway by binding cytochrome c released from mitochondria to the cytosol, thereby preventing cytochrome-c-mediated interaction of Apaf-1 with procaspase-9 and subsequent caspase activation.","method":"Cell-free caspase activation assay, co-immunoprecipitation of Hsp27 with cytochrome c, apoptosis assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1/2 — reconstituted cell-free system plus co-IP, >822 citations, mechanism precisely defined","pmids":["10980706"],"is_preprint":false},{"year":2000,"finding":"The C-terminal extension of mouse Hsp25 is required for full chaperone activity toward some substrates (dithiothreitol-reduced alpha-lactalbumin) but not others (thermally aggregating citrate synthase); deletion of the C-terminal extension reduces accessible hydrophobic surface and protein stability while the extension remains flexible during client interaction.","method":"1H NMR spectroscopy, analytical ultracentrifugation, electron microscopy, CD spectroscopy, chaperone assays with citrate synthase and alpha-lactalbumin","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal structural and functional methods in a single study","pmids":["10727931"],"is_preprint":false},{"year":2000,"finding":"Hsp25 overexpression provides radioresistance associated with upregulation of Bcl2, cell cycle delay, and reduced apoptosis; the radioresistance operates through pathways independent of cell-cycle synchronization alone.","method":"Stable transfection of Hsp25 in L929 cells, clonogenic survival assay, flow cytometry, immunoblotting","journal":"Radiation research","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO/KD with defined cellular phenotype, single lab","pmids":["11023606"],"is_preprint":false},{"year":2000,"finding":"Hsp25 overexpression in mouse L929 cells increases the glutathione pool by enhancing reduction of oxidized glutathione (GSSG) to GSH through elevated glutathione reductase and glutathione peroxidase activities, providing protection against ionizing radiation.","method":"Stable transfection, clonogenic radiation survival, glutathione composition analysis, enzyme activity assays","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway placement with enzyme activities, single lab","pmids":["10699971"],"is_preprint":false},{"year":2000,"finding":"Hsp110 forms a large native complex with hsc70 and hsp25; in vitro, purified hsp25, hsp70, and hsp110 spontaneously assemble into this complex and luciferase migrates into it after heat shock; the peptide-binding domain of hsp110 is required for its interaction with hsp25.","method":"Co-immunoprecipitation, in vitro reconstitution with purified proteins, deletion mutagenesis of hsp110","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP plus in vitro reconstitution, single lab","pmids":["10631312"],"is_preprint":false},{"year":2000,"finding":"HSP25/p38 MAPK pathway is necessary for cardiomyocyte differentiation of P19 cells: antisense HSP25 expression reduced cardiomyocyte differentiation and expression of cardiac actin and desmin, while inhibition of p38/SAPK2 by SB203580 blocked differentiation at an early mesodermal stage upstream of HSP25 induction.","method":"Antisense expression in P19 cells, p38 kinase inhibitor (SB203580), RT-PCR for cardiac markers, immunofluorescence","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function + chemical epistasis with clear phenotypic readout, single lab","pmids":["10656759"],"is_preprint":false},{"year":2001,"finding":"hsp27 physically interacts with hic-5/ARA55 through the hsp27 C-terminal domain and hic-5 LIM domains; this interaction inhibits the ability of hsp27 to protect cells against heat-induced death, as a non-interacting truncation mutant of hic-5 did not inhibit hsp27 protection.","method":"Yeast two-hybrid screen, co-immunoprecipitation, deletion mapping, heat shock cell survival assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2/3 — Y2H confirmed by co-IP with domain mapping plus functional consequence, single lab","pmids":["11546764"],"is_preprint":false},{"year":2001,"finding":"After sciatic nerve axotomy, p38 kinase activation is required for Hsp25 induction in spinal motor neurons, and Hsp25 forms a complex with Akt in these neurons, suggesting Hsp25 links p38 and PI-3K/Akt survival pathways.","method":"Sciatic nerve axotomy in vivo, kinase inhibition, co-immunoprecipitation of Hsp25 with Akt","journal":"Brain research. Molecular brain research","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP in vivo model with kinase inhibitor epistasis","pmids":["11589997"],"is_preprint":false},{"year":2001,"finding":"Stress-induced dissociation of large Hsp27 oligomers is mediated by two kinase cascades: p38 MAPK-activated MAPKAP kinase-2/3 (activated by metals, hypertonic stress, anisomycin) and protein kinase C (activated by phorbol ester); both kinases converge on Hsp27 phosphorylation.","method":"Sucrose density gradient centrifugation, specific kinase inhibitors (SB203580, staurosporine, bisindolylmaleimide), immunoassay","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological epistasis with multiple inhibitors and multiple stressors","pmids":["11525238"],"is_preprint":false},{"year":2002,"finding":"HSP25 phosphorylation (regulated by p38 MAPK) mediates its translocation to F-actin bundles and nuclear granules in heat-stressed myoblasts; association with actin filaments stabilizes them against subsequent cytochalasin or severe heat stress; only phosphorylated HSP25 isoforms associate with the cytoskeletal fraction.","method":"Immunofluorescence, Triton X-100 fractionation, isoform analysis, kinase inhibitors, cytochalasin treatment","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional consequence, multiple pharmacological controls","pmids":["12380682"],"is_preprint":false},{"year":2002,"finding":"HSP25-induced radioresistance requires downregulation of ERK2 but not ERK1: overexpression of ERK2 (but not ERK1) in Hsp25-overexpressing cells abolished radioresistance and reversed Hsp25-induced changes in cell cycle proteins (cyclin D1, cyclin A, cdc2) and Bcl-2 levels.","method":"Transient transfection of ERK1/ERK2, clonogenic survival assay, immunoblotting, MEK inhibitor PD98059","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with isoform specificity and multiple readouts, single lab","pmids":["11965498"],"is_preprint":false},{"year":2004,"finding":"Mutations in HSPB1 (Hsp27) cause axonal Charcot-Marie-Tooth disease (CMT2F) and distal hereditary motor neuropathy; four mutations cluster in the alpha-crystallin domain and one in the C-terminal region; mutant HSPB1-expressing neuronal cells showed reduced viability, and co-transfection of mutant HSPB1 with NEFL resulted in altered neurofilament assembly.","method":"Genetic linkage, mutation screening, neuronal cell transfection, cell viability assay, neurofilament assembly assay in cells lacking cytoplasmic intermediate filaments","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — human genetics combined with neuronal cell functional studies, >472 citations","pmids":["15122254"],"is_preprint":false},{"year":2005,"finding":"Cadmium activates p38 MAPK signaling in mesangial cells leading to sequential phosphorylation of HSP25 (Ser15 before Ser86), reduction of HSP25 oligomeric size, association of HSP25 with microfilaments, and mesangial cell contraction; SB-203580 inhibits all these responses, and dominant-negative p38 blocks HSP25 phosphorylation.","method":"Dominant-negative p38 transfection, p38 inhibitor SB-203580, phospho-site-specific analysis, microfilament association, cell contraction assay, isolated glomeruli experiments","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis (dominant-negative) plus pharmacology with multiple sequential mechanistic steps","pmids":["15687248"],"is_preprint":false},{"year":2007,"finding":"AKT phosphorylates HspB1 (Hsp27) in granular keratinocytes; Akt-mediated HspB1 phosphorylation promotes a transient interaction with filaggrin and intracellular redistribution of HspB1; loss of epidermal HspB1 causes hyperkeratinization and misprocessing of filaggrin.","method":"Conditional knockout of Akt in epidermis, co-immunoprecipitation of HspB1 with filaggrin, immunofluorescence, skin phenotype analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function in vivo phenotype + co-IP interaction with specific client protein, single lab","pmids":["17439945"],"is_preprint":false},{"year":2010,"finding":"In late-stage erythroid differentiation, HSP27 is phosphorylated in a p38-dependent manner, translocates to the nucleus, binds to GATA-1 transcription factor (when GATA-1 is acetylated), and promotes GATA-1 ubiquitination and proteasomal degradation; HSP27 depletion causes GATA-1 accumulation and impairs terminal erythroid maturation.","method":"siRNA knockdown of HSP27, co-immunoprecipitation of HSP27 with GATA-1, nuclear fractionation, ubiquitination assay, erythroid differentiation models (K562, CD34+ cells)","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP + p38 inhibitor epistasis + ubiquitination assay + two differentiation models","pmids":["20410505"],"is_preprint":false},{"year":2011,"finding":"BMP-2-induced cell migration requires activation of the p38/MK2/Hsp25 pathway; phosphorylated Hsp25 colocalizes with BMP receptor complexes in lamellipodia; a phosphorylation-deficient Hsp25 mutant abolishes BMP-2-induced migration; this pathway acts in parallel to the Cdc42/PAK/LIMK1 axis for actin remodeling.","method":"Chemical inhibition of p38/MK2, genetic ablation (p38α and MK2 knockout cells), phosphomutant overexpression, cell migration assay, immunofluorescence colocalization","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — genetic KO of two pathway components plus phosphomutant with clear migratory phenotype","pmids":["21297993"],"is_preprint":false},{"year":2012,"finding":"The N-terminal domain of Hsp27 encodes the determinants of oligomer-to-dimer equilibrium dissociation; cysteine mutagenesis identifies residues shifting the equilibrium; upon dissociation, N-terminal domain residues become solvent-exposed and dynamically disordered; substrate (T4 Lysozyme) binding involves N-terminal domain regions transitioning to a buried environment in the complex.","method":"Systematic cysteine mutagenesis, EPR spectroscopy with spin-labels, sucrose gradient sedimentation, substrate binding assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — structural EPR analysis with comprehensive mutagenesis and substrate binding measurements","pmids":["22264079"],"is_preprint":false},{"year":2013,"finding":"HSPB1 mutations causing CMT neuropathy increase Cdk5-mediated phosphorylation of neurofilaments (NFs), reduce NF binding to anterograde motor kinesin, and impair anterograde NF transport; Cdk5 inhibition rescues NF phosphorylation and kinesin binding in mutant HSPB1 cells.","method":"Stable transduction of neuronal cells with WT and mutant HSPB1, axonal transport assay, Cdk5 inhibition, co-immunoprecipitation of NF with kinesin","journal":"Acta neuropathologica","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway placement with rescue by Cdk5 inhibition, multiple readouts","pmids":["23728742"],"is_preprint":false},{"year":2013,"finding":"Extracellular HSP27 exerts proangiogenic effects via interaction with Toll-like receptor 3 (TLR3) on endothelial cells; this interaction (detected by immunoprecipitation) leads to internalization of HSP27/TLR3 to endosomes, cytosolic Ca2+-dependent NF-κB activation, increased VEGF transcription, and VEGF receptor-2 secretion promoting cell migration.","method":"Co-immunoprecipitation, SPR analysis, live-cell internalization imaging, NF-κB reporter assay, siRNA knockdown, chick chorioallantoic membrane angiogenesis assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with functional dissection via siRNA and inhibitors, single lab","pmids":["23804239"],"is_preprint":false},{"year":2014,"finding":"MMP9 cleaves HSPB1 and generates anti-angiogenic C-terminal fragments; the C-terminal HSPB1 fragment shows greater interaction with VEGF than full-length HSPB1 and inhibits VEGF-induced endothelial cell activation; HSPB1 cleavage occurs during lung tumor progression in vivo and is absent in MMP9-null mice.","method":"In vitro MMP9 cleavage assay, cleavage site mapping, VEGF binding assay, in vivo tumor models with WT and MMP9-null mice, immunofluorescence of tumor endothelium","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro cleavage with in vivo validation in knockout mice","pmids":["24465581"],"is_preprint":false},{"year":2015,"finding":"Phosphomimetic mutations at Ser15, Ser78, and Ser82 of Hsp27 progressively decrease average oligomeric size (triple mutant is predominantly a dimer); this correlates with enhanced chaperone activity against both amorphous and fibrillar protein aggregation; the data support dimers as the chaperone-active form.","method":"Native mass spectrometry, phosphomimetic mutagenesis, chaperone assays against amorphous and fibrillar aggregation","journal":"Chemistry & biology","confidence":"High","confidence_rationale":"Tier 1 — native MS with comprehensive phosphomimetic mutagenesis and functional chaperone assays","pmids":["25699602"],"is_preprint":false},{"year":2015,"finding":"HSPB1 is a negative regulator of ferroptosis: erastin-induced ferroptosis is mediated by HSF1-dependent HSPB1 upregulation, and protein kinase C-mediated HSPB1 phosphorylation reduces iron-mediated lipid ROS production; knockdown of HSF1 or HSPB1 enhances ferroptosis while HSPB1 overexpression or heat shock pretreatment inhibits it.","method":"siRNA knockdown of HSF1 and HSPB1, HSPB1 overexpression, PKC inhibition, lipid ROS measurement, iron metabolism assay, xenograft mouse model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — multiple gain/loss-of-function approaches with mechanistic pathway placement in vitro and in vivo","pmids":["25728673"],"is_preprint":false},{"year":2015,"finding":"HSP25 depletion in H9c2 cells increases p53 acetylation at K379 by reducing the interaction between SIRT1 and p53; HSP25 directly interacts with SIRT1 and its knockdown leads to dissociation of SIRT1 from p53, upregulation of Bax, cytochrome c release, and caspase-3/9 activation.","method":"Co-immunoprecipitation of HSP25 with SIRT1, siRNA knockdown, flow cytometry for apoptosis, immunoblotting for acetylated p53 and apoptotic markers","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2/3 — co-IP interaction with mechanistic pathway placement, single lab","pmids":["26515559"],"is_preprint":false},{"year":2016,"finding":"HSPB1 activates G6PD by enhancing its interaction with SIRT2, leading to SIRT2-mediated deacetylation and activation of G6PD; this sustains cellular NADPH and pentose phosphate production in response to oxidative stress or DNA damage.","method":"Co-immunoprecipitation of G6PD with SIRT2 in presence/absence of HSPB1, NADPH and pentose measurement, siRNA knockdown","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2/3 — co-IP with functional metabolic readouts, single lab","pmids":["27711253"],"is_preprint":false},{"year":2016,"finding":"Hsp27 promotes proteasomal degradation of ubiquitinated MST1 (the core Hippo kinase), thereby reducing phosphorylation/activity of LATS1 and MOB1, leading to YAP nuclear localization and activation; Hsp27 knockdown induces YAP phosphorylation and cytoplasmic retention, while overexpression has the opposite effect.","method":"Gain/loss-of-function experiments in prostate, breast, and lung cancer cells, co-immunoprecipitation, proteasome inhibition, phospho-YAP immunofluorescence","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — pathway placement via proteasome inhibition rescue + co-IP, replicated in three cancer types","pmids":["27555231"],"is_preprint":false},{"year":2018,"finding":"Membrane-associated androgen receptor (AR) activates HSP27, which in turn mediates AR membrane-to-nuclear signal transduction to potentiate transcriptional activity of nuclear AR; AR membrane transport depends on microtubule motor KIF5B, which physically interacts with AR in an androgen-enhanced manner.","method":"Co-immunoprecipitation and pulldown assays (AR with KIF5B and HSP27), siRNA knockdown of KIF5B, AR transcriptional reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2/3 — co-IP plus loss-of-function with transcriptional readout, single lab","pmids":["29934310"],"is_preprint":false},{"year":2018,"finding":"In intestinal mesenchymal cells, MK2-mediated Hsp27 phosphorylation is required for the production of tumorigenic effector molecules that drive epithelial proliferation, apoptosis, and angiogenesis; conditional MK2 deletion in intestinal mesenchymal cells reduces tumor growth in the Apcmin/+ model.","method":"Cell-type-specific conditional MK2 knockout mice (Apcmin/+ model), colitis-associated carcinogenesis model, tumor multiplicity and size analysis, mechanistic downstream analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — conditional genetic ablation in specific cell type with defined in vivo phenotype","pmids":["29844172"],"is_preprint":false},{"year":2019,"finding":"The redox state of HSP27 regulates its chaperone activity: reduction of disulfide bonds promotes monomer formation which are highly active chaperones but prone to self-aggregation; relaxation dispersion and high-pressure NMR reveal that the dimerization beta-strands in the alpha-crystallin domain partially unfold in monomers; neuropathy-causing mutations cluster to this dynamic region.","method":"Relaxation dispersion NMR, high-pressure NMR, chaperone activity assays in vitro, redox manipulation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — high-resolution NMR structural analysis with functional chaperone validation","pmids":["30842409"],"is_preprint":false},{"year":2019,"finding":"Wild-type HSPB1 interacts with the autophagy receptor SQSTM1/p62 via p62's PB1 domain; this interaction is necessary for SQSTM1/p62 body formation and subsequent autophagosome/phagophore formation; HSPB1 mutations associated with CMT neuropathy reduce p62 body formation and impair autophagic flux.","method":"LC-MS/MS interactome of WT and mutant HSPB1 variants, co-immunoprecipitation, HSPB1 knockout cells, rescue experiments, patient-derived motor neurons","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — MS-defined interaction + co-IP + domain mapping + KO rescue + patient-derived cells","pmids":["30669930"],"is_preprint":false},{"year":2020,"finding":"Ivermectin directly binds a phosphorylation pocket in the 24-monomer Hsp27 complex (composed of 12 dimers) flanked by serine residues between N-terminal domains, inhibiting MAPKAP2-mediated Hsp27 phosphorylation and depolymerization, thereby blocking Hsp27-regulated survival signaling and client-oncoprotein interactions.","method":"Biochemical, structural, and computational characterization of the 24-mer complex; direct binding assay; kinase phosphorylation assay; tumor models","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1/2 — structural definition of complex + direct binding + kinase assay + in vivo validation","pmids":["31845908"],"is_preprint":false},{"year":2020,"finding":"HspB1 chaperone activity toward tau (an amyloid-forming client) requires engagement of the disordered N-terminal region (NTR); ACD binding alone is insufficient for chaperone function; the tau-binding groove on the ACD also binds short hydrophobic regions within HspB1's own NTR, and mutations disrupting these intrinsic ACD-NTR interactions greatly enhance chaperone activity toward tau.","method":"In vitro chaperone assays, NMR, mutagenesis to disrupt intrinsic ACD-NTR interactions, domain deletion analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple NMR and in vitro functional approaches with mutagenesis, mechanistic model","pmids":["31974309"],"is_preprint":false},{"year":2021,"finding":"Human HSPB1 co-aggregates with unfolded substrates (firefly luciferase, lactate dehydrogenase) to form smaller, more regularly shaped aggregates; co-aggregated HSPB1 facilitates efficient disaggregation and refolding of substrates led by HSP70; HSPB1 homo-oligomerization is not required for this activity, and HSPB1 itself is extracted during disaggregation.","method":"In vitro co-aggregation assay, reconstituted disaggregation assay with HSP70, oligomerization-deficient mutants, substrate refolding measurement","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro system with mechanistic mutagenesis","pmids":["34429462"],"is_preprint":false},{"year":2021,"finding":"Bmal1 (circadian clock) regulates the redox state of HSPB1; Bmal1 knockdown decreases homooxidized HSPB1 (formed via S-thiolated modification at Cys141), and the HSPB1-C141S mutant increases cardiomyocyte apoptosis and ROS while decreasing GSH during oxidative stress.","method":"Bmal1 knockdown/overexpression in cardiomyocytes, HSPB1-C141S mutagenesis, ROS measurement, GSH/GSSG ratio, apoptosis assay, in vivo circadian rhythm disruption model","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 — site-specific mutagenesis with functional cellular readouts in vitro and in vivo","pmids":["34239687"],"is_preprint":false},{"year":2023,"finding":"FYN kinase phosphorylates TOPK/PBK at Y272, promoting TOPK activity that in turn phosphorylates HSPB1 at Ser15; the FYN-TOPK-HSPB1 cascade facilitates gastric cancer proliferation and metastasis.","method":"Co-IP, pulldown, 32P isotope kinase assays, phosphoproteomics, TOPK knockout mice, TOPK-Y272F mutation preventing FYN interaction","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro kinase assay + phosphoproteomics + KO mice, single lab","pmids":["37016377"],"is_preprint":false},{"year":2024,"finding":"crVDAC3 (a circular RNA) binds HSPB1 protein and inhibits its ubiquitination and degradation, leading to HSPB1 accumulation; knockdown of crVDAC3 reduces HSPB1 levels, increases ROS and labile iron pool, and induces ferroptosis; paritaprevir disrupts the crVDAC3-HSPB1 interaction to promote HSPB1 ubiquitination.","method":"RNA pull-down, mass spectrometry, RNA immunoprecipitation, co-immunoprecipitation, ferroptosis assays (C11-BODIPY, iron quantification), molecular docking, PDX model","journal":"Drug resistance updates","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal interaction methods with functional in vivo validation, single lab","pmids":["39243601"],"is_preprint":false},{"year":2024,"finding":"Reactive astrocytes secrete HSPB1 extracellularly; both astrocytes and neurons can take up astrocyte-secreted HSPB1; uptake is accompanied by attenuation of the inflammatory response in reactive astrocytes and reduced pathological tau inclusions in neurons, establishing a non-cell-autonomous chaperone protective mechanism.","method":"Conditioned medium transfer, live imaging of HSPB1 uptake, immunofluorescence of human AD brain, siRNA knockdown in astrocytes, tau inclusion assay in neurons","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — secretion/uptake demonstrated by imaging and transfer experiments with functional tau/inflammation readouts","pmids":["38507480"],"is_preprint":false}],"current_model":"HSPB1 (Hsp27) is an ATP-independent molecular chaperone that forms large, dynamic oligomers phosphorylated by MAPKAP kinase-2 downstream of p38 MAPK at Ser15, Ser78, and Ser82; phosphorylation dissociates oligomers to dimers/tetramers, altering chaperone activity toward clients (promoting activity toward amyloid-prone proteins like tau while reducing chaperone activity in thermal denaturation assays) and regulating actin filament stabilization; in the apoptotic pathway it sequesters cytochrome c to block Apaf-1/caspase-9 assembly; it modulates ferroptosis via PKC-dependent phosphorylation that reduces iron-mediated lipid ROS; it participates in autophagy by interacting with SQSTM1/p62 to promote phagophore formation; it controls client protein turnover (GATA-1, MST1) by linking them to ubiquitin-proteasomal degradation; and neuropathy-causing mutations in its alpha-crystallin domain disrupt oligomer dynamics, impair autophagy, and increase neurofilament hyperphosphorylation via Cdk5, causing axonal CMT2F/dHMN."},"narrative":{"teleology":[{"year":1992,"claim":"Identifying the upstream kinase for stress-induced HSPB1 phosphorylation resolved how extracellular signals control HSPB1 post-translational modification: MAPKAP kinase-2 phosphorylates Ser15, Ser78, and Ser82 downstream of p38 MAPK.","evidence":"In vitro kinase assay with co-purification and peptide mapping of phosphorylation sites","pmids":["1332886"],"confidence":"High","gaps":["Whether other kinases independently phosphorylate HSPB1 in vivo was not addressed","Stoichiometry and kinetics of phosphorylation at each site in living cells remained unknown"]},{"year":1993,"claim":"Establishing HSPB1 as an ATP-independent molecular chaperone defined its core biochemical activity: preventing aggregation of thermally or chemically unfolding proteins and promoting their refolding.","evidence":"Reconstituted in vitro chaperone assays with purified HSPB1 and multiple model substrates (citrate synthase, alpha-glucosidase)","pmids":["8093612"],"confidence":"High","gaps":["Mechanism of substrate recognition was undefined","Whether chaperone activity was regulated in vivo was unknown"]},{"year":1995,"claim":"Linking phosphorylation to actin stabilization revealed a non-chaperone effector function: phosphorylation-dependent oligomer dissociation is required for HSPB1 to protect microfilaments from heat- and drug-induced disruption.","evidence":"Wild-type vs. non-phosphorylatable (pm3) mutant HSPB1 stable transfection in hamster cells with cytochalasin and heat shock","pmids":["7799959"],"confidence":"High","gaps":["Direct binding interface between HSPB1 and F-actin was not mapped","Whether actin stabilization and chaperone holdase activity share the same binding surface was unknown"]},{"year":1999,"claim":"Phosphomimetic dissection showed that progressive phosphorylation shifts HSPB1 from large oligomers to tetramers/dimers; this oligomeric transition inversely controls thermal chaperone activity and oxidative stress protection, establishing the oligomer–activity paradigm.","evidence":"Phosphomimetic mutagenesis (S15D/S78D/S82D), gel filtration, thermal aggregation assay, cell survival in L929 and 13.S.1.24 cells","pmids":["10383393"],"confidence":"High","gaps":["Whether smaller species are more active toward all substrates or only some was untested","Structural basis of substrate binding by dimers vs. oligomers was unknown"]},{"year":2000,"claim":"Discovery that HSPB1 sequesters cytochrome c to block Apaf-1/caspase-9 assembly provided a direct molecular mechanism for its anti-apoptotic role, independent of its chaperone or actin functions.","evidence":"Cell-free caspase activation assay and co-immunoprecipitation of HSPB1 with cytochrome c","pmids":["10980706"],"confidence":"High","gaps":["Binding stoichiometry and affinity of HSPB1–cytochrome c interaction were not determined","Whether phosphorylation state affects cytochrome c binding was unexplored"]},{"year":2000,"claim":"Structural analysis of the C-terminal extension revealed substrate-selective roles: it is required for chaperone activity toward some but not all clients, and it remains flexible during client interaction, contributing to accessible hydrophobic surface.","evidence":"NMR, analytical ultracentrifugation, electron microscopy, and dual-substrate chaperone assays on Hsp25 C-terminal deletion mutants","pmids":["10727931"],"confidence":"High","gaps":["Which clients require the C-terminal extension and why was not systematically catalogued","Role of C-terminal extension in oligomer formation was not fully resolved"]},{"year":2004,"claim":"Identification of HSPB1 mutations as the genetic cause of CMT2F and distal hereditary motor neuropathy established the gene's essential role in axonal integrity; mutant HSPB1 disrupted neurofilament assembly and reduced neuronal viability.","evidence":"Genetic linkage and mutation screening in CMT2F/dHMN families; transfection of mutant HSPB1 in neuronal cells with neurofilament assembly assay","pmids":["15122254"],"confidence":"High","gaps":["Whether mutations act via loss-of-function, gain-of-toxic-function, or both was unresolved","The precise structural consequences of mutations on oligomer dynamics were unknown"]},{"year":2010,"claim":"Demonstrating that phosphorylated HSPB1 translocates to the nucleus, binds acetylated GATA-1, and promotes its ubiquitination and proteasomal degradation revealed a novel mechanism by which HSPB1 controls transcription factor turnover during erythroid differentiation.","evidence":"siRNA knockdown, reciprocal co-IP of HSPB1 with GATA-1, nuclear fractionation, ubiquitination assay in K562 and CD34+ erythroid differentiation models","pmids":["20410505"],"confidence":"High","gaps":["The E3 ligase recruited by HSPB1 for GATA-1 ubiquitination was not identified","Whether HSPB1 promotes degradation of other transcription factors via the same mechanism was untested"]},{"year":2012,"claim":"EPR spectroscopy of systematically spin-labeled HSPB1 mapped the N-terminal domain as the determinant of the oligomer–dimer equilibrium and showed that substrate binding buries N-terminal residues, structurally resolving how client engagement is coupled to oligomeric state.","evidence":"Systematic cysteine mutagenesis with EPR spectroscopy, sucrose gradient sedimentation, substrate (T4 lysozyme) binding assays","pmids":["22264079"],"confidence":"High","gaps":["Atomic-resolution structure of HSPB1 oligomer with bound substrate was lacking","How the N-terminal domain distinguishes different clients was not addressed"]},{"year":2013,"claim":"CMT-causing HSPB1 mutations were shown to increase Cdk5-mediated neurofilament hyperphosphorylation and impair kinesin-dependent anterograde transport, with Cdk5 inhibition rescuing the transport defect—providing a druggable pathomechanistic axis.","evidence":"Stable transduction of WT and mutant HSPB1 in neuronal cells, axonal transport assay, Cdk5 inhibition, co-IP of neurofilament with kinesin","pmids":["23728742"],"confidence":"High","gaps":["How HSPB1 mutations activate Cdk5 was not determined","Whether Cdk5 inhibition rescues axonal degeneration in vivo was untested"]},{"year":2015,"claim":"Native mass spectrometry resolved the full phosphorylation-dependent oligomeric landscape, demonstrating that triple-phosphomimetic HSPB1 exists predominantly as dimers with enhanced chaperone activity against both amorphous and fibrillar aggregation—reconciling earlier conflicting reports about phosphorylation and activity.","evidence":"Native MS of WT and progressive phosphomimetic mutants, chaperone assays against amorphous and amyloid aggregation","pmids":["25699602"],"confidence":"High","gaps":["Whether dimers are the sole chaperone-active species in cells was not confirmed in vivo","Phosphorylation heterogeneity within oligomers in native tissues remained unmeasured"]},{"year":2015,"claim":"HSPB1 was established as a negative regulator of ferroptosis: PKC-mediated phosphorylation of HSPB1 suppresses iron-dependent lipid ROS accumulation, defining a new cell death modality controlled by this chaperone.","evidence":"siRNA knockdown and overexpression of HSPB1, PKC inhibition, lipid ROS and iron measurements, xenograft model","pmids":["25728673"],"confidence":"High","gaps":["Direct molecular target through which HSPB1 controls iron metabolism was not identified","Whether chaperone activity or a distinct function mediates ferroptosis suppression was unclear"]},{"year":2016,"claim":"HSPB1 was shown to promote proteasomal degradation of MST1, the core Hippo pathway kinase, thereby activating YAP—extending its client-degradation function beyond GATA-1 to a key tumor-suppressor pathway.","evidence":"Gain/loss-of-function in prostate, breast, and lung cancer cells, co-IP, proteasome inhibition rescue, phospho-YAP immunofluorescence","pmids":["27555231"],"confidence":"Medium","gaps":["Whether HSPB1 directly binds MST1 or acts through an adaptor was not resolved","Ubiquitin ligase identity for MST1 degradation was not determined","Independent replication in non-cancer contexts is lacking"]},{"year":2019,"claim":"Relaxation dispersion NMR revealed that HSPB1 monomers (generated by disulfide reduction) are highly chaperone-active but conformationally unstable, with partial unfolding in the alpha-crystallin domain dimerization interface—the same region where neuropathy mutations cluster—linking structural dynamics to both function and disease.","evidence":"Relaxation dispersion and high-pressure NMR, redox manipulation, in vitro chaperone assays","pmids":["30842409"],"confidence":"High","gaps":["Whether monomer-driven chaperone activity is physiologically relevant given rapid dimerization tendency was unclear","Redox regulation of HSPB1 oligomeric state in vivo was not quantified"]},{"year":2019,"claim":"HSPB1 was found to interact with SQSTM1/p62 via its PB1 domain, and this interaction is required for p62 body formation and autophagosome biogenesis; CMT-linked mutations impair this interaction, directly connecting HSPB1-dependent autophagy to neuropathic disease.","evidence":"LC-MS/MS interactome, co-IP, domain mapping, HSPB1-KO rescue experiments, patient-derived motor neurons","pmids":["30669930"],"confidence":"High","gaps":["Whether autophagy impairment is the primary driver of CMT2F or acts in concert with neurofilament defects was unresolved","Structural basis of HSPB1–p62 PB1 domain interaction was not determined"]},{"year":2020,"claim":"NMR and mutagenesis showed that the tau-binding groove on the alpha-crystallin domain is autoinhibited by HSPB1's own N-terminal region; disrupting these intramolecular contacts greatly enhances chaperone activity toward tau, establishing a mechanism for regulated substrate access.","evidence":"In vitro chaperone assays with tau, NMR, ACD–NTR interaction-disrupting mutations, domain deletions","pmids":["31974309"],"confidence":"High","gaps":["Whether phosphorylation at the N-terminal domain releases autoinhibition in the same manner was not directly tested","In vivo relevance for tau pathology in neurodegenerative disease was not demonstrated"]},{"year":2021,"claim":"HSPB1 was shown to co-aggregate with unfolded substrates, reshaping aggregates into forms efficiently disaggregated by HSP70—redefining HSPB1's holdase function as an active co-aggregation and disaggregation-facilitating mechanism rather than passive aggregation prevention.","evidence":"Reconstituted in vitro co-aggregation and disaggregation assays with oligomerization-deficient mutants, substrate refolding measurement","pmids":["34429462"],"confidence":"High","gaps":["Whether co-aggregation occurs and is functionally relevant in cells was not demonstrated","Structural organization of HSPB1 within co-aggregates was not resolved"]},{"year":2024,"claim":"Demonstration that reactive astrocytes secrete HSPB1 and that neighboring neurons take it up—reducing pathological tau inclusions—established a non-cell-autonomous chaperone mechanism relevant to neurodegeneration.","evidence":"Conditioned medium transfer, live imaging of HSPB1 uptake, immunofluorescence of human AD brain, siRNA knockdown, tau inclusion assay","pmids":["38507480"],"confidence":"Medium","gaps":["Secretion mechanism (conventional vs. unconventional) is undefined","Quantitative contribution of extracellular HSPB1 relative to cell-autonomous pools in neuroprotection is unknown","Replication across independent labs is needed"]},{"year":null,"claim":"Key unresolved questions include: how phosphorylation heterogeneity within native HSPB1 oligomers controls substrate selectivity in vivo; the identity of E3 ubiquitin ligases recruited by HSPB1 for client degradation; whether gain-of-toxic-function versus loss-of-chaperone-function underlies CMT2F; and the mechanistic basis by which HSPB1 modulates iron metabolism to suppress ferroptosis.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of a full-length HSPB1 oligomer with bound client","Relative contribution of autophagy impairment vs. neurofilament transport defects in CMT2F pathogenesis","Direct ferroptosis-relevant molecular target of HSPB1 is unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[1,3,5,24,31,34,35]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2,13,16,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,25,28,32]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,3,4,24,35]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[2,13,16,19]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[13,18]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[22,39]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,1,3,7,12,25,36]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,25,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,19,28,30]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[18,28,35]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[32]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[22]}],"complexes":["Hsp25/Hsp70/Hsp110 chaperone complex"],"partners":["MAPKAPK2","SQSTM1","GATA1","SIRT1","MST1","TLR3","TGFB1I1","G6PD"],"other_free_text":[]},"mechanistic_narrative":"HSPB1 (Hsp27) is an ATP-independent small heat shock protein that functions as a molecular chaperone, anti-apoptotic factor, and cytoskeletal regulator, with its diverse activities controlled by phosphorylation-dependent oligomeric dynamics. It forms large (~24-mer) oligomers that dissociate to chaperone-active dimers upon phosphorylation at Ser15, Ser78, and Ser82 by MAPKAP kinase-2 (downstream of p38 MAPK) or protein kinase C; the N-terminal domain encodes the oligomer–dimer equilibrium determinants and is essential for substrate engagement, while the alpha-crystallin domain harbors a client-binding groove also used for autoinhibitory intramolecular contacts [PMID:1332886, PMID:10383393, PMID:25699602, PMID:31974309, PMID:22264079]. Phosphorylated HSPB1 stabilizes actin filaments, promotes BMP-2-induced cell migration, co-aggregates with unfolded substrates to facilitate Hsp70-mediated disaggregation, negatively regulates ferroptosis by suppressing iron-mediated lipid ROS, sequesters cytochrome c to block Apaf-1/caspase-9-dependent apoptosis, and directs client proteins (GATA-1, MST1) to ubiquitin–proteasomal degradation [PMID:7799959, PMID:10980706, PMID:34429462, PMID:25728673, PMID:20410505, PMID:27555231]. Mutations in the alpha-crystallin domain cause axonal Charcot-Marie-Tooth disease type 2F (CMT2F) and distal hereditary motor neuropathy by disrupting oligomer dynamics, impairing SQSTM1/p62-dependent autophagy, and increasing Cdk5-mediated neurofilament hyperphosphorylation that compromises axonal transport [PMID:15122254, PMID:23728742, PMID:30669930]."},"prefetch_data":{"uniprot":{"accession":"P04792","full_name":"Heat shock protein beta-1","aliases":["28 kDa heat shock protein","Estrogen-regulated 24 kDa protein","Heat shock 27 kDa protein","HSP 27","Heat shock protein family B member 1","Stress-responsive protein 27","SRP27"],"length_aa":205,"mass_kda":22.8,"function":"Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742)","subcellular_location":"Cytoplasm; Nucleus; Cytoplasm, cytoskeleton, spindle","url":"https://www.uniprot.org/uniprotkb/P04792/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HSPB1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000106211","cell_line_id":"CID000050","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"G3BP1","stoichiometry":10.0},{"gene":"DYNC1H1","stoichiometry":0.2},{"gene":"ALG9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000050","total_profiled":1310},"omim":[{"mim_id":"613568","title":"ZINC FINGER, MYM-TYPE 4; ZMYM4","url":"https://www.omim.org/entry/613568"},{"mim_id":"613376","title":"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 4; HMND4","url":"https://www.omim.org/entry/613376"},{"mim_id":"610695","title":"HEAT-SHOCK 27-KD PROTEIN 6; HSPB6","url":"https://www.omim.org/entry/610695"},{"mim_id":"609708","title":"LIPOPROTEIN LIPASE; LPL","url":"https://www.omim.org/entry/609708"},{"mim_id":"608673","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L","url":"https://www.omim.org/entry/608673"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"esophagus","ntpm":6918.5}],"url":"https://www.proteinatlas.org/search/HSPB1"},"hgnc":{"alias_symbol":["HSP27","HSP28","Hs.76067","Hsp25","CMT2F"],"prev_symbol":[]},"alphafold":{"accession":"P04792","domains":[{"cath_id":"2.60.40.790","chopping":"109-173","consensus_level":"medium","plddt":91.4432,"start":109,"end":173}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04792","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04792-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04792-F1-predicted_aligned_error_v6.png","plddt_mean":68.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HSPB1","jax_strain_url":"https://www.jax.org/strain/search?query=HSPB1"},"sequence":{"accession":"P04792","fasta_url":"https://rest.uniprot.org/uniprotkb/P04792.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04792/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04792"}},"corpus_meta":[{"pmid":"25728673","id":"PMC_25728673","title":"HSPB1 as a novel regulator of ferroptotic cancer cell death.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25728673","citation_count":540,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8411230","id":"PMC_8411230","title":"Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.","date":"1993","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/8411230","citation_count":490,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12510153","id":"PMC_12510153","title":"On the role of Hsp27 in regulating apoptosis.","date":"2003","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/12510153","citation_count":437,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22564335","id":"PMC_22564335","title":"Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target.","date":"2012","source":"Fibrogenesis & tissue repair","url":"https://pubmed.ncbi.nlm.nih.gov/22564335","citation_count":222,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8277336","id":"PMC_8277336","title":"Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease.","date":"1993","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8277336","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33053445","id":"PMC_33053445","title":"Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27.","date":"2020","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/33053445","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10727931","id":"PMC_10727931","title":"Mouse Hsp25, a small shock protein. The role of its C-terminal extension in oligomerization and chaperone action.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10727931","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25699602","id":"PMC_25699602","title":"Phosphomimics destabilize Hsp27 oligomeric assemblies and enhance chaperone activity.","date":"2015","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/25699602","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12713516","id":"PMC_12713516","title":"Exercise-induced HSP27, HSP70 and MAPK responses in human skeletal muscle.","date":"2003","source":"Acta physiologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/12713516","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10656759","id":"PMC_10656759","title":"Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10656759","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23804239","id":"PMC_23804239","title":"Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3.","date":"2013","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/23804239","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30842409","id":"PMC_30842409","title":"Local unfolding of the HSP27 monomer regulates chaperone activity.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30842409","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10699971","id":"PMC_10699971","title":"Role of small heat shock protein HSP25 in radioresistance and glutathione-redox cycle.","date":"2000","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10699971","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1541812","id":"PMC_1541812","title":"Growth arrest of human B lymphocytes is accompanied by induction of the low molecular weight mammalian heat shock protein (Hsp28).","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1541812","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11589997","id":"PMC_11589997","title":"Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury.","date":"2001","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11589997","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22264079","id":"PMC_22264079","title":"Sequence, structure, and dynamic determinants of Hsp27 (HspB1) equilibrium dissociation are encoded by the N-terminal domain.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22264079","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39243601","id":"PMC_39243601","title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer.","date":"2024","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/39243601","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17439945","id":"PMC_17439945","title":"AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17439945","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22627320","id":"PMC_22627320","title":"Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo.","date":"2012","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22627320","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15646035","id":"PMC_15646035","title":"Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats.","date":"2004","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15646035","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20410505","id":"PMC_20410505","title":"HSP27 controls GATA-1 protein level during erythroid cell differentiation.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20410505","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30669930","id":"PMC_30669930","title":"Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30669930","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11799090","id":"PMC_11799090","title":"Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II.","date":"2002","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/11799090","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12380682","id":"PMC_12380682","title":"Distribution, phosphorylation, and activities of Hsp25 in heat-stressed H9c2 myoblasts: a functional link to cytoprotection.","date":"2002","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/12380682","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31845908","id":"PMC_31845908","title":"Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31845908","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22176143","id":"PMC_22176143","title":"HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients.","date":"2011","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/22176143","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20514530","id":"PMC_20514530","title":"HspB1 (Hsp 27) expression and neuroprotection in the retina.","date":"2010","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20514530","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11546764","id":"PMC_11546764","title":"Identification and characterization of hic-5/ARA55 as an hsp27 binding protein.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11546764","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27555231","id":"PMC_27555231","title":"Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27555231","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19330846","id":"PMC_19330846","title":"The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition.","date":"2009","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/19330846","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11528513","id":"PMC_11528513","title":"A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21.","date":"2001","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/11528513","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20536836","id":"PMC_20536836","title":"HSPB1, actin filament dynamics, and aging cells.","date":"2010","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20536836","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24265026","id":"PMC_24265026","title":"Overexpression of a Metarhizium robertsii HSP25 gene increases thermotolerance and survival in soil.","date":"2013","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/24265026","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23728742","id":"PMC_23728742","title":"Charcot-Marie-Tooth causing HSPB1 mutations increase Cdk5-mediated phosphorylation of neurofilaments.","date":"2013","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/23728742","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29749377","id":"PMC_29749377","title":"P2RX7-MAPK1/2-SP1 axis inhibits MTOR independent HSPB1-mediated astroglial autophagy.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29749377","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31974309","id":"PMC_31974309","title":"Release of a disordered domain enhances HspB1 chaperone activity toward tau.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31974309","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10631312","id":"PMC_10631312","title":"Characterization of native interaction of hsp110 with hsp25 and hsc70.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10631312","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27711253","id":"PMC_27711253","title":"HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27711253","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26941848","id":"PMC_26941848","title":"A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma.","date":"2016","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/26941848","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19289101","id":"PMC_19289101","title":"Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19289101","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23996744","id":"PMC_23996744","title":"HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.","date":"2013","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23996744","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16340246","id":"PMC_16340246","title":"Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell.","date":"2005","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16340246","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11525238","id":"PMC_11525238","title":"Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27.","date":"2001","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/11525238","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12820652","id":"PMC_12820652","title":"Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin.","date":"2003","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/12820652","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15687248","id":"PMC_15687248","title":"p38 MAPK/HSP25 signaling mediates cadmium-induced contraction of mesangial cells and renal glomeruli.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15687248","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35453647","id":"PMC_35453647","title":"The Role of Hsp27 in Chemotherapy Resistance.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35453647","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21297993","id":"PMC_21297993","title":"The p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migration.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21297993","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18575275","id":"PMC_18575275","title":"HSP27: an anti-inflammatory and immunomodulatory stress protein acting to dampen immune function.","date":"2008","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/18575275","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27029009","id":"PMC_27029009","title":"R-Ras Inhibits VEGF-Induced p38MAPK Activation and HSP27 Phosphorylation in Endothelial Cells.","date":"2016","source":"Journal of vascular research","url":"https://pubmed.ncbi.nlm.nih.gov/27029009","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29844172","id":"PMC_29844172","title":"Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29844172","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23530261","id":"PMC_23530261","title":"Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function.","date":"2013","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23530261","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8435441","id":"PMC_8435441","title":"Responses to heat shock of alpha B crystallin and HSP28 in U373 MG human glioma cells.","date":"1993","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8435441","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22804237","id":"PMC_22804237","title":"Role of human and mouse HspB1 in metastasis.","date":"2012","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22804237","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26141737","id":"PMC_26141737","title":"Overexpression of mutant HSP27 causes axonal neuropathy in mice.","date":"2015","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/26141737","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23165430","id":"PMC_23165430","title":"Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.","date":"2012","source":"Prostate cancer and prostatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23165430","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9061315","id":"PMC_9061315","title":"Heat-shock protein 27 (HSP27) and its role in female reproductive organs.","date":"1997","source":"European journal of gynaecological oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9061315","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29934310","id":"PMC_29934310","title":"Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27).","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29934310","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11023606","id":"PMC_11023606","title":"Hsp25-induced radioresistance is associated with reduction of death by apoptosis: involvement of Bcl2 and the cell cycle.","date":"2000","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/11023606","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38507480","id":"PMC_38507480","title":"Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/38507480","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33834331","id":"PMC_33834331","title":"Bio-indicators in cadmium toxicity: Role of HSP27 and HSP70.","date":"2021","source":"Environmental science and pollution research international","url":"https://pubmed.ncbi.nlm.nih.gov/33834331","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11774370","id":"PMC_11774370","title":"Expression pattern of HSP25 in mouse preimplantation embryo: heat shock responses during oocyte maturation.","date":"2002","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/11774370","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26675522","id":"PMC_26675522","title":"Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress.","date":"2015","source":"BBA clinical","url":"https://pubmed.ncbi.nlm.nih.gov/26675522","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27012766","id":"PMC_27012766","title":"Melatonin reverses morphine tolerance by inhibiting microglia activation and HSP27 expression.","date":"2016","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27012766","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34429462","id":"PMC_34429462","title":"The chaperone HSPB1 prepares protein aggregates for resolubilization by HSP70.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34429462","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9108202","id":"PMC_9108202","title":"Strong expression of heat shock proteins in growth plate cartilage, an immunohistochemical study of HSP28, HSP70 and HSP110.","date":"1997","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/9108202","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21898231","id":"PMC_21898231","title":"Structure-functions of HspB1 (Hsp27).","date":"2011","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/21898231","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23767669","id":"PMC_23767669","title":"Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors.","date":"2013","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23767669","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26842818","id":"PMC_26842818","title":"Advances in HSP27 and HSP90-targeting strategies for glioblastoma.","date":"2016","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26842818","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27830184","id":"PMC_27830184","title":"Novel HSPB1 mutation causes both motor neuronopathy and distal myopathy.","date":"2016","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27830184","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1618914","id":"PMC_1618914","title":"Development of acute thermotolerance in L929 cells: lack of HSP28 synthesis and phosphorylation.","date":"1992","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1618914","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27449291","id":"PMC_27449291","title":"Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27449291","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11893238","id":"PMC_11893238","title":"Induction of adaptive response by low-dose radiation in RIF cells transfected with Hspb1 (Hsp25) or inducible Hspa (Hsp70).","date":"2002","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/11893238","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26805817","id":"PMC_26805817","title":"The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26805817","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38640858","id":"PMC_38640858","title":"Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38640858","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34239687","id":"PMC_34239687","title":"Bmal1 Regulates the Redox Rhythm of HSPB1, and Homooxidized HSPB1 Attenuates the Oxidative Stress Injury of Cardiomyocytes.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/34239687","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24465581","id":"PMC_24465581","title":"MMP9 processing of HSPB1 regulates tumor progression.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24465581","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11004667","id":"PMC_11004667","title":"p53-dependent induction of heat shock protein 27 (HSP27) expression.","date":"2000","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11004667","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11965498","id":"PMC_11965498","title":"Downregulation of ERK2 is essential for the inhibition of radiation-induced cell death in HSP25 overexpressed L929 cells.","date":"2002","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/11965498","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37016377","id":"PMC_37016377","title":"FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/37016377","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30902393","id":"PMC_30902393","title":"The effects of HSP27 against UVB-induced photoaging in rat skin.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30902393","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28797631","id":"PMC_28797631","title":"HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons.","date":"2017","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28797631","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24985029","id":"PMC_24985029","title":"αB-crystallin and HSP27 in glial cells in tauopathies.","date":"2014","source":"Neuropathology : official journal of the Japanese Society of Neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/24985029","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26515559","id":"PMC_26515559","title":"HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis.","date":"2015","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/26515559","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15153566","id":"PMC_15153566","title":"Differential inhibition of HSP72 and HSP25 produces profound impairment of cellular integrity.","date":"2004","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/15153566","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32301006","id":"PMC_32301006","title":"Mutations in HspB1 and hereditary neuropathies.","date":"2020","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/32301006","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24337777","id":"PMC_24337777","title":"3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes.","date":"2013","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/24337777","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28275338","id":"PMC_28275338","title":"Sustained HSP25 Expression Induces Clasmatodendrosis via ER Stress in the Rat Hippocampus.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28275338","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24898650","id":"PMC_24898650","title":"Modulation of amyloid-β protein precursor expression by HspB1.","date":"2014","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/24898650","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36611161","id":"PMC_36611161","title":"The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis.","date":"2023","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/36611161","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18202113","id":"PMC_18202113","title":"Flagellin is required for salmonella-induced expression of heat shock protein Hsp25 in intestinal epithelium.","date":"2008","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18202113","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27626679","id":"PMC_27626679","title":"HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27626679","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31870551","id":"PMC_31870551","title":"Melanoma migration is promoted by prion protein via Akt-hsp27 signaling axis.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31870551","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19553351","id":"PMC_19553351","title":"Hsp27 inhibits sublethal, Src-mediated renal epithelial cell injury.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19553351","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23313812","id":"PMC_23313812","title":"Small heat shock protein HSPB1 regulates growth of embryonic zebrafish craniofacial muscles.","date":"2013","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/23313812","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36474716","id":"PMC_36474716","title":"HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans.","date":"2022","source":"Cardiovascular therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/36474716","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27714564","id":"PMC_27714564","title":"Heat shock protein-27 (HSP27) regulates STAT3 and eIF4G levels in first trimester human placenta.","date":"2016","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/27714564","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12592567","id":"PMC_12592567","title":"Different expression of 25-kDa heat-shock protein (Hsp25) in Meckel's cartilage compared with other cartilages in the mouse.","date":"2003","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/12592567","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33792343","id":"PMC_33792343","title":"HSP25 Vaccination Attenuates Atherogenesis via Upregulation of LDLR Expression, Lowering of PCSK9 Levels and Curbing of Inflammation.","date":"2021","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33792343","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34649353","id":"PMC_34649353","title":"HSPB1 inhibitor J2 attenuates lung inflammation through direct modulation of Ym1 production and paracrine signaling.","date":"2021","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/34649353","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30279146","id":"PMC_30279146","title":"Dependence of HSP27 cellular level on protein kinase CK2 discloses novel therapeutic strategies.","date":"2018","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/30279146","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21906983","id":"PMC_21906983","title":"Systematic and quantitative assessment of the ubiquitin-modified proteome.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21906983","citation_count":1334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16916647","id":"PMC_16916647","title":"Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.","date":"2006","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16916647","citation_count":1260,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8093612","id":"PMC_8093612","title":"Small heat shock proteins are molecular chaperones.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8093612","citation_count":1035,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10980706","id":"PMC_10980706","title":"Hsp27 negatively regulates cell death by interacting with cytochrome c.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10980706","citation_count":822,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10383393","id":"PMC_10383393","title":"Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10383393","citation_count":626,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7799959","id":"PMC_7799959","title":"Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7799959","citation_count":568,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17110338","id":"PMC_17110338","title":"Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17110338","citation_count":517,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21565611","id":"PMC_21565611","title":"Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21565611","citation_count":507,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1332886","id":"PMC_1332886","title":"Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins.","date":"1992","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1332886","citation_count":498,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21423176","id":"PMC_21423176","title":"Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21423176","citation_count":490,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15122254","id":"PMC_15122254","title":"Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy.","date":"2004","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15122254","citation_count":472,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47767,"output_tokens":7703,"usd":0.129423},"stage2":{"model":"claude-opus-4-6","input_tokens":11516,"output_tokens":3904,"usd":0.23277},"total_usd":0.807865,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":59645,"output_tokens":9460,"usd":0.160417},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":13559,"output_tokens":4895,"usd":0.285255}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"HSPB1 is a negative regulator of ferroptosis; erastin stimulates HSF1-dependent HSPB1 expression, and protein kinase C (PKC)-mediated HSPB1 phosphorylation confers protection against ferroptosis by reducing iron-mediated production of lipid reactive oxygen species.\",\n      \"method\": \"siRNA knockdown, overexpression, PKC inhibition, xenograft mouse models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD, OE, pharmacological inhibition, in vivo) with defined mechanistic readout\",\n      \"pmids\": [\"25728673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Phosphorylation of HSPB1 at serines 15, 78, and 82 (mimicked by phosphomimetic mutations) destabilizes large oligomers, promoting dissociation toward dimers, and enhances chaperone activity against both amorphous and fibrillar aggregation; dimers are the chaperone-active species.\",\n      \"method\": \"Mass spectrometry of oligomeric states, phosphomimetic mutagenesis, chaperone aggregation assays\",\n      \"journal\": \"Chemistry & Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and MS structural analysis in a single rigorous study\",\n      \"pmids\": [\"25699602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Redox-induced reduction of HSPB1 disulfide bonds generates monomers that are highly active chaperones; within the monomer, the pair of β-strands mediating dimerization partially unfold as observed by NMR, and numerous neuropathy-associated mutations cluster to this dynamic region.\",\n      \"method\": \"High-pressure NMR, relaxation dispersion NMR, in vitro chaperone assay\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural NMR with functional validation in one study\",\n      \"pmids\": [\"30842409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HSPB1 chaperone activity toward tau requires interactions via the disordered N-terminal region (NTR), not the alpha-crystallin domain (ACD) binding groove; the ACD groove sequesters the NTR intramolecularly, and mutations disrupting this ACD-NTR interaction enhance chaperone activity by releasing the NTR.\",\n      \"method\": \"In vitro chaperone assays, binding studies, mutagenesis of ACD groove and NTR\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"31974309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HSPB1 co-aggregates with unfolded substrates (firefly luciferase, lactate dehydrogenase) to form smaller, more regular aggregates, and these co-aggregates are more efficiently disaggregated and refolded by the HSP70 machinery; HSPB1 homo-oligomerization is not required for this activity.\",\n      \"method\": \"In vitro reconstitution of co-aggregation and disaggregation, HSP70-led refolding assay\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple substrates and mechanistic mutagenesis\",\n      \"pmids\": [\"34429462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The C-terminal extension of mouse Hsp25 is required for full chaperone activity against DTT-reduced alpha-lactalbumin but not for thermal aggregation protection of citrate synthase; 1H NMR shows the C-terminal extension retains flexibility during client interaction.\",\n      \"method\": \"NMR spectroscopy, CD spectroscopy, analytical ultracentrifugation, chaperone aggregation assays with C-terminal deletion mutant\",\n      \"journal\": \"European Journal of Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural NMR combined with functional assays and mutagenesis\",\n      \"pmids\": [\"10727931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hsp27 oligomer dissociation and equilibrium between large oligomers and dimers is encoded by the N-terminal domain; EPR analysis shows that dissociation to dimer exposes the N-terminal domain, and substrate (T4 lysozyme) binding involves unstructured, flexible regions of the N-terminal domain.\",\n      \"method\": \"Cysteine mutagenesis, EPR spin-labeling, substrate-binding assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis combined with EPR structural analysis and substrate binding\",\n      \"pmids\": [\"22264079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Stress-induced dissociation of Hsp27 oligomers is driven by phosphorylation via two kinase cascades: (1) p38 MAPK → MAPKAP kinase-2/3 and (2) protein kinase C; SB203580 blocks p38-dependent dissociation and phorbol ester-induced dissociation is blocked by PKC inhibitors.\",\n      \"method\": \"Sucrose density gradient fractionation, pharmacological kinase inhibitors\",\n      \"journal\": \"Cell Stress & Chaperones\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with multiple specific inhibitors, replicated across stress conditions\",\n      \"pmids\": [\"11525238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Ivermectin directly binds a phosphorylation pocket in the 24-monomer HSP27 complex (formed by 12 dimers), inhibiting MAPKAP2-mediated phosphorylation and depolymerization of HSP27, thereby blocking HSP27-regulated survival signaling and client-oncoprotein interactions.\",\n      \"method\": \"Biochemical, structural, and computational characterization of HSP27 complex; ivermectin-binding assay; inhibition of MAPKAP2-mediated phosphorylation; tumor models\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multistep structural and biochemical characterization with functional validation in vivo\",\n      \"pmids\": [\"31845908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MAPKAP Kinase 2 (MK2) directly phosphorylates HSP27; a cell-permeant peptide inhibitor of MK2 reduces HSP27 phosphorylation in vitro and inhibits TGF-β1-induced HSP27 phosphorylation in fibroblasts.\",\n      \"method\": \"In vitro kinase assay with MK2 inhibitor peptide, cell-based phosphorylation assay\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and cell-based assay, single lab\",\n      \"pmids\": [\"19289101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HSP27 is phosphorylated in a p38-dependent manner during late erythroid differentiation, translocates to the nucleus, binds GATA-1, and promotes its ubiquitination and proteasomal degradation (dependent on GATA-1 acetylation); HSP27 depletion causes GATA-1 accumulation and impairs terminal erythroid maturation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, ubiquitination assay, erythroid differentiation models (K562 and CD34+ cells)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, mechanistic pathway in two cell models with defined phenotype\",\n      \"pmids\": [\"20410505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hsp27 promotes proteasomal degradation of ubiquitinated MST1 (the core Hippo kinase), reducing phosphorylation/activity of LATS1 and MOB1, which increases nuclear YAP activity; Hsp27 knockdown induces YAP phosphorylation and cytoplasmic retention.\",\n      \"method\": \"Gain/loss-of-function in multiple cancer cell lines, functional genomics, proteasome inhibition experiments\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — epistasis established in multiple cell lines with pharmacological and genetic tools, single lab\",\n      \"pmids\": [\"27555231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HSPB1 enhances the interaction between G6PD and SIRT2, promoting SIRT2-mediated deacetylation and activation of G6PD, thereby sustaining cellular NADPH and pentose production in response to oxidative stress.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/knockdown, G6PD activity assay\",\n      \"journal\": \"PLOS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with functional enzymatic assay, single lab\",\n      \"pmids\": [\"27711253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HSPB1 mutations (neuropathy-associated) impair autophagosome formation and macroautophagic flux; wild-type HSPB1 binds the autophagy receptor SQSTM1/p62 via its PB1 domain, and mutations reduce SQSTM1/p62 body formation and phagophore initiation.\",\n      \"method\": \"HSPB1 knockout cells, LC-MS/MS interactome, Co-IP, autophagy flux assays, patient-derived motor neurons\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-identified interaction confirmed by Co-IP, KO rescue, patient neurons\",\n      \"pmids\": [\"30669930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CMT-causing HSPB1 mutations increase Cdk5-mediated phosphorylation of neurofilaments (NFs), reduce NF binding to kinesin, and impair anterograde axonal transport of NFs; Cdk5 inhibition rescues NF phosphorylation and kinesin binding.\",\n      \"method\": \"Stable transduction of neuronal cells with WT/mutant HSPB1, axonal transport assays, Cdk5 inhibition\",\n      \"journal\": \"Acta Neuropathologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by kinase inhibition, defined transport phenotype\",\n      \"pmids\": [\"23728742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In differentiating granular keratinocytes, AKT phosphorylates HspB1, promoting a transient interaction between HspB1 and filaggrin and intracellular redistribution of HspB1; loss of HspB1 causes hyperkeratinization and filaggrin misprocessing.\",\n      \"method\": \"Conditional knockout, overexpression, co-immunoprecipitation, immunofluorescence in developing skin\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP interaction, KO phenotype with specific substrate identified\",\n      \"pmids\": [\"17439945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Extracellular HSP27 interacts with Toll-like receptor 3 (TLR3) on endothelial cells (detected by immunoprecipitation), and is co-internalized with TLR3 to the endosomal compartment, triggering NF-κB activation in a cytosolic Ca2+-dependent manner, leading to VEGF transcription and angiogenesis.\",\n      \"method\": \"Immunoprecipitation, SPR analysis, internalization imaging, NF-κB reporter assays, migration assays, chick chorioallantoic membrane\",\n      \"journal\": \"FASEB Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — interaction shown by Co-IP, direct binding not confirmed by SPR; functional consequences characterized\",\n      \"pmids\": [\"23804239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hsp27 (Hsp25) forms a complex with Akt in spinal motor neurons after axotomy; activation of p38 is required for Hsp25 expression induction in this context.\",\n      \"method\": \"Co-immunoprecipitation in spinal motor neurons after sciatic nerve injury, pharmacological p38 inhibition\",\n      \"journal\": \"Brain Research Molecular Brain Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP from in vivo tissue with pharmacological epistasis\",\n      \"pmids\": [\"11589997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hsp27 interacts with hic-5/ARA55 (a focal adhesion protein) via the hic-5 LIM domains and the hsp27 C-terminal domain; hic-5 inhibits hsp27-mediated protection against heat-induced cell death in an interaction-dependent manner.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, domain-mapping with truncation mutants, co-transfection survival assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by Co-IP with domain mapping, functional consequence shown\",\n      \"pmids\": [\"11546764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hsp110 forms a large native complex with hsc70 and hsp25; these three proteins directly interact in vitro and substrate (luciferase) migrates into this complex after heat shock; the peptide-binding domain of hsp110 is required for interaction with hsp25 but not hsc70.\",\n      \"method\": \"Co-immunoprecipitation, in vitro reconstitution with purified proteins, hsp110 deletion mutants\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP combined with in vitro reconstitution and domain mapping\",\n      \"pmids\": [\"10631312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Phosphorylated Hsp25 associates specifically with F-actin bundles (cytoskeletal fraction) after mild heat stress in H9c2 myoblasts, and this association stabilizes actin filaments against cytochalasin and severe heat stress; phosphorylation-blocking drugs prevent both nuclear granulation and F-actin association.\",\n      \"method\": \"Triton X-100 fractionation, immunofluorescence, isoform analysis, pharmacological inhibitors of phosphorylation\",\n      \"journal\": \"Cell Stress & Chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation and imaging with pharmacological intervention showing phosphorylation dependence\",\n      \"pmids\": [\"12380682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HSP25 overexpression radioresistance is associated with downregulation of ERK2 (but not ERK1); ERK2 re-expression abolishes HSP25-mediated radioresistance, cell cycle changes, and Bcl-2 upregulation.\",\n      \"method\": \"Stable transfection, ERK1/2 overexpression epistasis, clonogenic survival, flow cytometry\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by overexpression of ERK isoforms in HSP25-overexpressing cells\",\n      \"pmids\": [\"11965498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Overexpression of mouse Hsp25 enhances glutathione-redox cycling (increased GRd and GPx activities, elevated GSH/GSSG ratio) and provides radioresistance and reduced radiation-induced apoptosis.\",\n      \"method\": \"Stable transfection, glutathione assays, GRd/GPx activity assays, clonogenic survival, apoptosis assays\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional mechanistic link established by overexpression with enzymatic assays\",\n      \"pmids\": [\"10699971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BMP-2 activates the p38/MK2/Hsp25 signaling pathway in mesenchymal cells; phosphorylated Hsp25 colocalizes with BMP receptor complexes in lamellipodia; a phosphorylation-deficient Hsp25 mutant abolishes BMP-2-induced cell migration, establishing this pathway as required for BMP-2-induced actin remodeling and migration.\",\n      \"method\": \"Genetic ablation (p38α or MK2 KO), pharmacological inhibition, phosphomimetic/phosphodead Hsp25 mutants, immunofluorescence co-localization\",\n      \"journal\": \"PLOS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with KO + pharmacological inhibition + mutagenesis, converging on same phenotype\",\n      \"pmids\": [\"21297993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HSPB1 drives mTOR-independent astroglial autophagy (clasmatodendrosis) by activating ER stress and promoting AMPK1/ULK1- and AKT1/GSK3B/SH3GLB1-mediated autophagic pathways; P2RX7 suppresses HSPB1 expression via MAPK1/2-SP1 phosphorylation.\",\n      \"method\": \"P2rx7 knockout, siRNA, pharmacological inhibitors, in vivo status epilepticus model\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and KD with pathway analysis, but mechanistic links are inferred\",\n      \"pmids\": [\"29749377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HSP25 phosphorylation by p38 MAPK in mesangial cells is sequential (Ser15 before Ser86), reduces oligomeric size, and drives association with microfilaments, resulting in cadmium-induced cell contraction; dominant-negative p38 prevents phosphorylation and contraction.\",\n      \"method\": \"Dominant-negative p38, SB-203580, phosphorylation site analysis, microfilament association assay, glomerular contraction assay\",\n      \"journal\": \"American Journal of Physiology - Renal Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with DN-p38 and pharmacological inhibitor, mechanistic site ordering\",\n      \"pmids\": [\"15687248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MK2 in intestinal mesenchymal cells phosphorylates Hsp27, and this MK2/Hsp27 axis is required for production of tumorigenic effector molecules (affecting epithelial proliferation, apoptosis, and angiogenesis) in intestinal carcinogenesis.\",\n      \"method\": \"Conditional cell-type-specific MK2 knockout in mice, Apcmin/+ and colitis-associated carcinogenesis models\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with genetic epistasis in vivo, replicated in two tumor models\",\n      \"pmids\": [\"29844172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MMP9 cleaves extracellular HSPB1; C-terminal HSPB1 fragments show greater interaction with VEGF than full-length HSPB1 and inhibit VEGF-induced endothelial cell activation, with anti-angiogenic effects in tumor progression models.\",\n      \"method\": \"In vitro MMP9 cleavage assay, cleavage site mapping, VEGF interaction assays, MMP9-null mouse tumor models\",\n      \"journal\": \"PLOS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro cleavage with domain mapping, validated in MMP9 KO mice\",\n      \"pmids\": [\"24465581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Membrane-associated androgen receptor (AR) activates HSP27, and HSP27 mediates AR membrane-to-nuclear signal transduction to potentiate nuclear AR transcriptional activity; AR membrane transport requires the motor protein KIF5B.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, KIF5B knockdown, HSP27 manipulation\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and pulldown with functional consequence on transcription\",\n      \"pmids\": [\"29934310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HSP25 interacts with SIRT1 (but not HSP90, HSP70, or HSP20); knockdown of HSP25 decreases SIRT1-p53 interaction, leading to increased p53 acetylation at K379, upregulated Bax, cytochrome c release, and caspase-3/9 activation in doxorubicin-treated H9c2 cells.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, p53 acetylation assays, apoptosis assays\",\n      \"journal\": \"Cell Stress & Chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP showing SIRT1 interaction, epistasis linking HSP25 to p53 acetylation via SIRT1\",\n      \"pmids\": [\"26515559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CK2 regulates HSP27 cellular turnover by controlling the expression of the HSP27 ubiquitin ligase SMURF2; CK2 and HSP27 interact (shown by Co-IP, confocal microscopy, and density gradient).\",\n      \"method\": \"CRISPR/Cas9 KO cell lines, specific kinase inhibitors, siRNA, Co-immunoprecipitation, confocal immunofluorescence, density gradient separation\",\n      \"journal\": \"BBA General Subjects\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods showing interaction and mechanistic link to SMURF2\",\n      \"pmids\": [\"30279146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In the miR-15b-Smurf2-HSP27 axis, decreased Smurf2 expression (driven by increased miR-15b) leads to accumulation of phosphorylated HSP27 in pulmonary fibrosis; Smurf2 ubiquitinates HSP27 for degradation.\",\n      \"method\": \"Mouse fibrosis models, miRNA modulation, Smurf2 knockdown/overexpression, patient tissue\",\n      \"journal\": \"Journal of Biomedical Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo model with genetic manipulation and patient validation, single lab\",\n      \"pmids\": [\"36611161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The circular RNA crVDAC3 binds HSPB1 protein and inhibits its ubiquitination and proteasomal degradation, leading to HSPB1 accumulation that suppresses ferroptosis (reducing ROS and labile iron pool) in breast cancer cells.\",\n      \"method\": \"RNA pull-down, mass spectrometry, RNA immunoprecipitation, co-immunoprecipitation, ferroptosis assays, PDX models\",\n      \"journal\": \"Drug Resistance Updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods identifying crRNA-HSPB1 interaction and functional consequence\",\n      \"pmids\": [\"39243601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HSPB1 is secreted from reactive astrocytes into the extracellular space; secreted HSPB1 is taken up by neurons and astrocytes, attenuates the inflammatory response in reactive astrocytes, and reduces pathological tau inclusions in a non-cell-autonomous manner.\",\n      \"method\": \"Human AD brain immunohistochemistry, astrocyte secretion assays, uptake experiments, tau inclusion assays\",\n      \"journal\": \"Science Advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct secretion assay, cellular uptake, functional consequences in human brain and cell models\",\n      \"pmids\": [\"38507480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Wild-type HSPB1 binds SQSTM1/p62 (and forms complexes required for autophagic flux); neuropathy mutations impair this interaction and reduce p62 body formation; identified by LC-MS/MS interactome and confirmed by Co-IP.\",\n      \"method\": \"LC-MS/MS interactome, Co-IP, domain mapping (PB1 domain of SQSTM1), HSPB1 KO rescue\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-identified interaction confirmed by Co-IP with domain mapping and KO rescue in patient neurons\",\n      \"pmids\": [\"30669930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FYN phosphorylates TOPK at Y272, and TOPK in turn phosphorylates HSPB1 at Ser15; this FYN-TOPK-HSPB1 cascade facilitates gastric cancer proliferation and metastasis.\",\n      \"method\": \"COIP, pull-down, 32P isotope kinase assay, TOPK knockout mice, phosphoproteomics, immunofluorescence co-localization\",\n      \"journal\": \"Journal of Experimental & Clinical Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro kinase assay and Co-IP with phosphospecific antibody validation\",\n      \"pmids\": [\"37016377\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSPB1 (Hsp27) is an ATP-independent molecular chaperone whose activity is tightly regulated by oligomeric state and phosphorylation: p38 MAPK→MAPKAP kinase-2/3 and PKC phosphorylate three serines (S15, S78, S82), dissociating large oligomers into chaperone-active dimers/monomers; the disordered N-terminal domain mediates substrate binding while the ACD beta-strand interface undergoes partial unfolding upon monomer release; HSPB1 co-aggregates with misfolded clients to facilitate HSP70-led disaggregation, protects against ferroptosis by reducing lipid ROS via iron metabolism modulation (PKC-dependent), controls the actin cytoskeleton through phosphorylation-dependent F-actin association, regulates apoptosis by interacting with SIRT1/p53 and the cytochrome c pathway, directs client protein (e.g., GATA-1, MST1) to ubiquitin-proteasomal degradation, and is secreted from astrocytes to exert non-cell-autonomous neuroprotection.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"MAPKAP kinase-2 (MK2) is the major kinase responsible for phosphorylating small mammalian heat shock proteins, phosphorylating Ser15 and Ser86 of murine Hsp25 and Ser15, Ser78, and Ser82 of human Hsp27 in response to growth factors and heat shock.\",\n      \"method\": \"In vitro kinase assay, co-purification, peptide substrate mapping\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with site-specific phosphorylation mapping, foundational paper with >498 citations, independently confirmed\",\n      \"pmids\": [\"1332886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Murine Hsp25 and human Hsp27 function as ATP-independent molecular chaperones, preventing aggregation of unfolding proteins (citrate synthase, alpha-glucosidase) under heat shock conditions and promoting their refolding after urea denaturation.\",\n      \"method\": \"In vitro chaperone assay with purified proteins, thermal aggregation and refolding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with multiple substrates, foundational paper >1000 citations\",\n      \"pmids\": [\"8093612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Phosphorylation of HSP27 by MAPKAP kinase reduces its large oligomeric size and is required for actin filament stabilization; phosphorylated HSP27 protects microfilaments from heat-induced disruption and accelerates actin recovery, while a non-phosphorylatable mutant (HSP27-pm3) fails to provide these protective effects.\",\n      \"method\": \"Stable transfection of wild-type and phosphorylation-site mutant HSP27 in Chinese hamster cells; cytochalasin D treatment; heat shock survival; immunofluorescence of actin\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with phosphomutants plus multiple functional readouts, >568 citations, replicated\",\n      \"pmids\": [\"7799959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Phosphorylation of Hsp27/Hsp25 at Ser15, Ser78, Ser82 (mimicked by S15D/S78D/S82D triple mutant) causes dissociation of large oligomers to tetramers, significantly decreases chaperone activity in thermal denaturation and refolding assays, and abolishes protection against oxidative stress when overexpressed in cells.\",\n      \"method\": \"In vitro phosphorylation, phosphomimetic mutagenesis, gel filtration, thermal aggregation assay, cell survival assays in L929 and 13.S.1.24 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution + mutagenesis + cell-based functional assays, >626 citations\",\n      \"pmids\": [\"10383393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hsp27 inhibits the mitochondrial apoptotic pathway by binding cytochrome c released from mitochondria to the cytosol, thereby preventing cytochrome-c-mediated interaction of Apaf-1 with procaspase-9 and subsequent caspase activation.\",\n      \"method\": \"Cell-free caspase activation assay, co-immunoprecipitation of Hsp27 with cytochrome c, apoptosis assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — reconstituted cell-free system plus co-IP, >822 citations, mechanism precisely defined\",\n      \"pmids\": [\"10980706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The C-terminal extension of mouse Hsp25 is required for full chaperone activity toward some substrates (dithiothreitol-reduced alpha-lactalbumin) but not others (thermally aggregating citrate synthase); deletion of the C-terminal extension reduces accessible hydrophobic surface and protein stability while the extension remains flexible during client interaction.\",\n      \"method\": \"1H NMR spectroscopy, analytical ultracentrifugation, electron microscopy, CD spectroscopy, chaperone assays with citrate synthase and alpha-lactalbumin\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal structural and functional methods in a single study\",\n      \"pmids\": [\"10727931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hsp25 overexpression provides radioresistance associated with upregulation of Bcl2, cell cycle delay, and reduced apoptosis; the radioresistance operates through pathways independent of cell-cycle synchronization alone.\",\n      \"method\": \"Stable transfection of Hsp25 in L929 cells, clonogenic survival assay, flow cytometry, immunoblotting\",\n      \"journal\": \"Radiation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO/KD with defined cellular phenotype, single lab\",\n      \"pmids\": [\"11023606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hsp25 overexpression in mouse L929 cells increases the glutathione pool by enhancing reduction of oxidized glutathione (GSSG) to GSH through elevated glutathione reductase and glutathione peroxidase activities, providing protection against ionizing radiation.\",\n      \"method\": \"Stable transfection, clonogenic radiation survival, glutathione composition analysis, enzyme activity assays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway placement with enzyme activities, single lab\",\n      \"pmids\": [\"10699971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hsp110 forms a large native complex with hsc70 and hsp25; in vitro, purified hsp25, hsp70, and hsp110 spontaneously assemble into this complex and luciferase migrates into it after heat shock; the peptide-binding domain of hsp110 is required for its interaction with hsp25.\",\n      \"method\": \"Co-immunoprecipitation, in vitro reconstitution with purified proteins, deletion mutagenesis of hsp110\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus in vitro reconstitution, single lab\",\n      \"pmids\": [\"10631312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HSP25/p38 MAPK pathway is necessary for cardiomyocyte differentiation of P19 cells: antisense HSP25 expression reduced cardiomyocyte differentiation and expression of cardiac actin and desmin, while inhibition of p38/SAPK2 by SB203580 blocked differentiation at an early mesodermal stage upstream of HSP25 induction.\",\n      \"method\": \"Antisense expression in P19 cells, p38 kinase inhibitor (SB203580), RT-PCR for cardiac markers, immunofluorescence\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function + chemical epistasis with clear phenotypic readout, single lab\",\n      \"pmids\": [\"10656759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"hsp27 physically interacts with hic-5/ARA55 through the hsp27 C-terminal domain and hic-5 LIM domains; this interaction inhibits the ability of hsp27 to protect cells against heat-induced death, as a non-interacting truncation mutant of hic-5 did not inhibit hsp27 protection.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, deletion mapping, heat shock cell survival assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — Y2H confirmed by co-IP with domain mapping plus functional consequence, single lab\",\n      \"pmids\": [\"11546764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"After sciatic nerve axotomy, p38 kinase activation is required for Hsp25 induction in spinal motor neurons, and Hsp25 forms a complex with Akt in these neurons, suggesting Hsp25 links p38 and PI-3K/Akt survival pathways.\",\n      \"method\": \"Sciatic nerve axotomy in vivo, kinase inhibition, co-immunoprecipitation of Hsp25 with Akt\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP in vivo model with kinase inhibitor epistasis\",\n      \"pmids\": [\"11589997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Stress-induced dissociation of large Hsp27 oligomers is mediated by two kinase cascades: p38 MAPK-activated MAPKAP kinase-2/3 (activated by metals, hypertonic stress, anisomycin) and protein kinase C (activated by phorbol ester); both kinases converge on Hsp27 phosphorylation.\",\n      \"method\": \"Sucrose density gradient centrifugation, specific kinase inhibitors (SB203580, staurosporine, bisindolylmaleimide), immunoassay\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis with multiple inhibitors and multiple stressors\",\n      \"pmids\": [\"11525238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HSP25 phosphorylation (regulated by p38 MAPK) mediates its translocation to F-actin bundles and nuclear granules in heat-stressed myoblasts; association with actin filaments stabilizes them against subsequent cytochalasin or severe heat stress; only phosphorylated HSP25 isoforms associate with the cytoskeletal fraction.\",\n      \"method\": \"Immunofluorescence, Triton X-100 fractionation, isoform analysis, kinase inhibitors, cytochalasin treatment\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence, multiple pharmacological controls\",\n      \"pmids\": [\"12380682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HSP25-induced radioresistance requires downregulation of ERK2 but not ERK1: overexpression of ERK2 (but not ERK1) in Hsp25-overexpressing cells abolished radioresistance and reversed Hsp25-induced changes in cell cycle proteins (cyclin D1, cyclin A, cdc2) and Bcl-2 levels.\",\n      \"method\": \"Transient transfection of ERK1/ERK2, clonogenic survival assay, immunoblotting, MEK inhibitor PD98059\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with isoform specificity and multiple readouts, single lab\",\n      \"pmids\": [\"11965498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mutations in HSPB1 (Hsp27) cause axonal Charcot-Marie-Tooth disease (CMT2F) and distal hereditary motor neuropathy; four mutations cluster in the alpha-crystallin domain and one in the C-terminal region; mutant HSPB1-expressing neuronal cells showed reduced viability, and co-transfection of mutant HSPB1 with NEFL resulted in altered neurofilament assembly.\",\n      \"method\": \"Genetic linkage, mutation screening, neuronal cell transfection, cell viability assay, neurofilament assembly assay in cells lacking cytoplasmic intermediate filaments\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetics combined with neuronal cell functional studies, >472 citations\",\n      \"pmids\": [\"15122254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cadmium activates p38 MAPK signaling in mesangial cells leading to sequential phosphorylation of HSP25 (Ser15 before Ser86), reduction of HSP25 oligomeric size, association of HSP25 with microfilaments, and mesangial cell contraction; SB-203580 inhibits all these responses, and dominant-negative p38 blocks HSP25 phosphorylation.\",\n      \"method\": \"Dominant-negative p38 transfection, p38 inhibitor SB-203580, phospho-site-specific analysis, microfilament association, cell contraction assay, isolated glomeruli experiments\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (dominant-negative) plus pharmacology with multiple sequential mechanistic steps\",\n      \"pmids\": [\"15687248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"AKT phosphorylates HspB1 (Hsp27) in granular keratinocytes; Akt-mediated HspB1 phosphorylation promotes a transient interaction with filaggrin and intracellular redistribution of HspB1; loss of epidermal HspB1 causes hyperkeratinization and misprocessing of filaggrin.\",\n      \"method\": \"Conditional knockout of Akt in epidermis, co-immunoprecipitation of HspB1 with filaggrin, immunofluorescence, skin phenotype analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in vivo phenotype + co-IP interaction with specific client protein, single lab\",\n      \"pmids\": [\"17439945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In late-stage erythroid differentiation, HSP27 is phosphorylated in a p38-dependent manner, translocates to the nucleus, binds to GATA-1 transcription factor (when GATA-1 is acetylated), and promotes GATA-1 ubiquitination and proteasomal degradation; HSP27 depletion causes GATA-1 accumulation and impairs terminal erythroid maturation.\",\n      \"method\": \"siRNA knockdown of HSP27, co-immunoprecipitation of HSP27 with GATA-1, nuclear fractionation, ubiquitination assay, erythroid differentiation models (K562, CD34+ cells)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP + p38 inhibitor epistasis + ubiquitination assay + two differentiation models\",\n      \"pmids\": [\"20410505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BMP-2-induced cell migration requires activation of the p38/MK2/Hsp25 pathway; phosphorylated Hsp25 colocalizes with BMP receptor complexes in lamellipodia; a phosphorylation-deficient Hsp25 mutant abolishes BMP-2-induced migration; this pathway acts in parallel to the Cdc42/PAK/LIMK1 axis for actin remodeling.\",\n      \"method\": \"Chemical inhibition of p38/MK2, genetic ablation (p38α and MK2 knockout cells), phosphomutant overexpression, cell migration assay, immunofluorescence colocalization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO of two pathway components plus phosphomutant with clear migratory phenotype\",\n      \"pmids\": [\"21297993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The N-terminal domain of Hsp27 encodes the determinants of oligomer-to-dimer equilibrium dissociation; cysteine mutagenesis identifies residues shifting the equilibrium; upon dissociation, N-terminal domain residues become solvent-exposed and dynamically disordered; substrate (T4 Lysozyme) binding involves N-terminal domain regions transitioning to a buried environment in the complex.\",\n      \"method\": \"Systematic cysteine mutagenesis, EPR spectroscopy with spin-labels, sucrose gradient sedimentation, substrate binding assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural EPR analysis with comprehensive mutagenesis and substrate binding measurements\",\n      \"pmids\": [\"22264079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HSPB1 mutations causing CMT neuropathy increase Cdk5-mediated phosphorylation of neurofilaments (NFs), reduce NF binding to anterograde motor kinesin, and impair anterograde NF transport; Cdk5 inhibition rescues NF phosphorylation and kinesin binding in mutant HSPB1 cells.\",\n      \"method\": \"Stable transduction of neuronal cells with WT and mutant HSPB1, axonal transport assay, Cdk5 inhibition, co-immunoprecipitation of NF with kinesin\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway placement with rescue by Cdk5 inhibition, multiple readouts\",\n      \"pmids\": [\"23728742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Extracellular HSP27 exerts proangiogenic effects via interaction with Toll-like receptor 3 (TLR3) on endothelial cells; this interaction (detected by immunoprecipitation) leads to internalization of HSP27/TLR3 to endosomes, cytosolic Ca2+-dependent NF-κB activation, increased VEGF transcription, and VEGF receptor-2 secretion promoting cell migration.\",\n      \"method\": \"Co-immunoprecipitation, SPR analysis, live-cell internalization imaging, NF-κB reporter assay, siRNA knockdown, chick chorioallantoic membrane angiogenesis assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with functional dissection via siRNA and inhibitors, single lab\",\n      \"pmids\": [\"23804239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MMP9 cleaves HSPB1 and generates anti-angiogenic C-terminal fragments; the C-terminal HSPB1 fragment shows greater interaction with VEGF than full-length HSPB1 and inhibits VEGF-induced endothelial cell activation; HSPB1 cleavage occurs during lung tumor progression in vivo and is absent in MMP9-null mice.\",\n      \"method\": \"In vitro MMP9 cleavage assay, cleavage site mapping, VEGF binding assay, in vivo tumor models with WT and MMP9-null mice, immunofluorescence of tumor endothelium\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro cleavage with in vivo validation in knockout mice\",\n      \"pmids\": [\"24465581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Phosphomimetic mutations at Ser15, Ser78, and Ser82 of Hsp27 progressively decrease average oligomeric size (triple mutant is predominantly a dimer); this correlates with enhanced chaperone activity against both amorphous and fibrillar protein aggregation; the data support dimers as the chaperone-active form.\",\n      \"method\": \"Native mass spectrometry, phosphomimetic mutagenesis, chaperone assays against amorphous and fibrillar aggregation\",\n      \"journal\": \"Chemistry & biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — native MS with comprehensive phosphomimetic mutagenesis and functional chaperone assays\",\n      \"pmids\": [\"25699602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HSPB1 is a negative regulator of ferroptosis: erastin-induced ferroptosis is mediated by HSF1-dependent HSPB1 upregulation, and protein kinase C-mediated HSPB1 phosphorylation reduces iron-mediated lipid ROS production; knockdown of HSF1 or HSPB1 enhances ferroptosis while HSPB1 overexpression or heat shock pretreatment inhibits it.\",\n      \"method\": \"siRNA knockdown of HSF1 and HSPB1, HSPB1 overexpression, PKC inhibition, lipid ROS measurement, iron metabolism assay, xenograft mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple gain/loss-of-function approaches with mechanistic pathway placement in vitro and in vivo\",\n      \"pmids\": [\"25728673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HSP25 depletion in H9c2 cells increases p53 acetylation at K379 by reducing the interaction between SIRT1 and p53; HSP25 directly interacts with SIRT1 and its knockdown leads to dissociation of SIRT1 from p53, upregulation of Bax, cytochrome c release, and caspase-3/9 activation.\",\n      \"method\": \"Co-immunoprecipitation of HSP25 with SIRT1, siRNA knockdown, flow cytometry for apoptosis, immunoblotting for acetylated p53 and apoptotic markers\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — co-IP interaction with mechanistic pathway placement, single lab\",\n      \"pmids\": [\"26515559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HSPB1 activates G6PD by enhancing its interaction with SIRT2, leading to SIRT2-mediated deacetylation and activation of G6PD; this sustains cellular NADPH and pentose phosphate production in response to oxidative stress or DNA damage.\",\n      \"method\": \"Co-immunoprecipitation of G6PD with SIRT2 in presence/absence of HSPB1, NADPH and pentose measurement, siRNA knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — co-IP with functional metabolic readouts, single lab\",\n      \"pmids\": [\"27711253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hsp27 promotes proteasomal degradation of ubiquitinated MST1 (the core Hippo kinase), thereby reducing phosphorylation/activity of LATS1 and MOB1, leading to YAP nuclear localization and activation; Hsp27 knockdown induces YAP phosphorylation and cytoplasmic retention, while overexpression has the opposite effect.\",\n      \"method\": \"Gain/loss-of-function experiments in prostate, breast, and lung cancer cells, co-immunoprecipitation, proteasome inhibition, phospho-YAP immunofluorescence\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placement via proteasome inhibition rescue + co-IP, replicated in three cancer types\",\n      \"pmids\": [\"27555231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Membrane-associated androgen receptor (AR) activates HSP27, which in turn mediates AR membrane-to-nuclear signal transduction to potentiate transcriptional activity of nuclear AR; AR membrane transport depends on microtubule motor KIF5B, which physically interacts with AR in an androgen-enhanced manner.\",\n      \"method\": \"Co-immunoprecipitation and pulldown assays (AR with KIF5B and HSP27), siRNA knockdown of KIF5B, AR transcriptional reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — co-IP plus loss-of-function with transcriptional readout, single lab\",\n      \"pmids\": [\"29934310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In intestinal mesenchymal cells, MK2-mediated Hsp27 phosphorylation is required for the production of tumorigenic effector molecules that drive epithelial proliferation, apoptosis, and angiogenesis; conditional MK2 deletion in intestinal mesenchymal cells reduces tumor growth in the Apcmin/+ model.\",\n      \"method\": \"Cell-type-specific conditional MK2 knockout mice (Apcmin/+ model), colitis-associated carcinogenesis model, tumor multiplicity and size analysis, mechanistic downstream analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional genetic ablation in specific cell type with defined in vivo phenotype\",\n      \"pmids\": [\"29844172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The redox state of HSP27 regulates its chaperone activity: reduction of disulfide bonds promotes monomer formation which are highly active chaperones but prone to self-aggregation; relaxation dispersion and high-pressure NMR reveal that the dimerization beta-strands in the alpha-crystallin domain partially unfold in monomers; neuropathy-causing mutations cluster to this dynamic region.\",\n      \"method\": \"Relaxation dispersion NMR, high-pressure NMR, chaperone activity assays in vitro, redox manipulation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution NMR structural analysis with functional chaperone validation\",\n      \"pmids\": [\"30842409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Wild-type HSPB1 interacts with the autophagy receptor SQSTM1/p62 via p62's PB1 domain; this interaction is necessary for SQSTM1/p62 body formation and subsequent autophagosome/phagophore formation; HSPB1 mutations associated with CMT neuropathy reduce p62 body formation and impair autophagic flux.\",\n      \"method\": \"LC-MS/MS interactome of WT and mutant HSPB1 variants, co-immunoprecipitation, HSPB1 knockout cells, rescue experiments, patient-derived motor neurons\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-defined interaction + co-IP + domain mapping + KO rescue + patient-derived cells\",\n      \"pmids\": [\"30669930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Ivermectin directly binds a phosphorylation pocket in the 24-monomer Hsp27 complex (composed of 12 dimers) flanked by serine residues between N-terminal domains, inhibiting MAPKAP2-mediated Hsp27 phosphorylation and depolymerization, thereby blocking Hsp27-regulated survival signaling and client-oncoprotein interactions.\",\n      \"method\": \"Biochemical, structural, and computational characterization of the 24-mer complex; direct binding assay; kinase phosphorylation assay; tumor models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — structural definition of complex + direct binding + kinase assay + in vivo validation\",\n      \"pmids\": [\"31845908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HspB1 chaperone activity toward tau (an amyloid-forming client) requires engagement of the disordered N-terminal region (NTR); ACD binding alone is insufficient for chaperone function; the tau-binding groove on the ACD also binds short hydrophobic regions within HspB1's own NTR, and mutations disrupting these intrinsic ACD-NTR interactions greatly enhance chaperone activity toward tau.\",\n      \"method\": \"In vitro chaperone assays, NMR, mutagenesis to disrupt intrinsic ACD-NTR interactions, domain deletion analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple NMR and in vitro functional approaches with mutagenesis, mechanistic model\",\n      \"pmids\": [\"31974309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human HSPB1 co-aggregates with unfolded substrates (firefly luciferase, lactate dehydrogenase) to form smaller, more regularly shaped aggregates; co-aggregated HSPB1 facilitates efficient disaggregation and refolding of substrates led by HSP70; HSPB1 homo-oligomerization is not required for this activity, and HSPB1 itself is extracted during disaggregation.\",\n      \"method\": \"In vitro co-aggregation assay, reconstituted disaggregation assay with HSP70, oligomerization-deficient mutants, substrate refolding measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro system with mechanistic mutagenesis\",\n      \"pmids\": [\"34429462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Bmal1 (circadian clock) regulates the redox state of HSPB1; Bmal1 knockdown decreases homooxidized HSPB1 (formed via S-thiolated modification at Cys141), and the HSPB1-C141S mutant increases cardiomyocyte apoptosis and ROS while decreasing GSH during oxidative stress.\",\n      \"method\": \"Bmal1 knockdown/overexpression in cardiomyocytes, HSPB1-C141S mutagenesis, ROS measurement, GSH/GSSG ratio, apoptosis assay, in vivo circadian rhythm disruption model\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-specific mutagenesis with functional cellular readouts in vitro and in vivo\",\n      \"pmids\": [\"34239687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FYN kinase phosphorylates TOPK/PBK at Y272, promoting TOPK activity that in turn phosphorylates HSPB1 at Ser15; the FYN-TOPK-HSPB1 cascade facilitates gastric cancer proliferation and metastasis.\",\n      \"method\": \"Co-IP, pulldown, 32P isotope kinase assays, phosphoproteomics, TOPK knockout mice, TOPK-Y272F mutation preventing FYN interaction\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro kinase assay + phosphoproteomics + KO mice, single lab\",\n      \"pmids\": [\"37016377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"crVDAC3 (a circular RNA) binds HSPB1 protein and inhibits its ubiquitination and degradation, leading to HSPB1 accumulation; knockdown of crVDAC3 reduces HSPB1 levels, increases ROS and labile iron pool, and induces ferroptosis; paritaprevir disrupts the crVDAC3-HSPB1 interaction to promote HSPB1 ubiquitination.\",\n      \"method\": \"RNA pull-down, mass spectrometry, RNA immunoprecipitation, co-immunoprecipitation, ferroptosis assays (C11-BODIPY, iron quantification), molecular docking, PDX model\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal interaction methods with functional in vivo validation, single lab\",\n      \"pmids\": [\"39243601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Reactive astrocytes secrete HSPB1 extracellularly; both astrocytes and neurons can take up astrocyte-secreted HSPB1; uptake is accompanied by attenuation of the inflammatory response in reactive astrocytes and reduced pathological tau inclusions in neurons, establishing a non-cell-autonomous chaperone protective mechanism.\",\n      \"method\": \"Conditioned medium transfer, live imaging of HSPB1 uptake, immunofluorescence of human AD brain, siRNA knockdown in astrocytes, tau inclusion assay in neurons\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — secretion/uptake demonstrated by imaging and transfer experiments with functional tau/inflammation readouts\",\n      \"pmids\": [\"38507480\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSPB1 (Hsp27) is an ATP-independent molecular chaperone that forms large, dynamic oligomers phosphorylated by MAPKAP kinase-2 downstream of p38 MAPK at Ser15, Ser78, and Ser82; phosphorylation dissociates oligomers to dimers/tetramers, altering chaperone activity toward clients (promoting activity toward amyloid-prone proteins like tau while reducing chaperone activity in thermal denaturation assays) and regulating actin filament stabilization; in the apoptotic pathway it sequesters cytochrome c to block Apaf-1/caspase-9 assembly; it modulates ferroptosis via PKC-dependent phosphorylation that reduces iron-mediated lipid ROS; it participates in autophagy by interacting with SQSTM1/p62 to promote phagophore formation; it controls client protein turnover (GATA-1, MST1) by linking them to ubiquitin-proteasomal degradation; and neuropathy-causing mutations in its alpha-crystallin domain disrupt oligomer dynamics, impair autophagy, and increase neurofilament hyperphosphorylation via Cdk5, causing axonal CMT2F/dHMN.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HSPB1 (Hsp27) is an ATP-independent small heat shock protein that functions as a phosphorylation-regulated molecular chaperone, cytoskeletal organizer, and signaling scaffold with roles in proteostasis, ferroptosis suppression, autophagy, and apoptosis. Its chaperone activity is governed by oligomeric state: large 24-mer oligomers are held inactive by intramolecular sequestration of the disordered N-terminal region (NTR) within the alpha-crystallin domain groove, while phosphorylation at Ser15/78/82 by p38–MK2 or PKC cascades—or redox-driven disulfide reduction—dissociates oligomers into dimers and monomers that expose the NTR for substrate binding, co-aggregate with misfolded clients to facilitate HSP70-mediated disaggregation, and associate with F-actin to stabilize the cytoskeleton and drive cell migration [PMID:25699602, PMID:30842409, PMID:31974309, PMID:34429462, PMID:12380682, PMID:21297993]. Beyond classical chaperoning, HSPB1 directs specific client proteins (GATA-1, MST1) to ubiquitin–proteasomal degradation, scaffolds SIRT1–p53 and G6PD–SIRT2 interactions to regulate apoptosis and redox metabolism, binds SQSTM1/p62 to promote autophagosome formation, and suppresses ferroptosis by reducing iron-dependent lipid ROS in a PKC-phosphorylation-dependent manner [PMID:20410505, PMID:27555231, PMID:26515559, PMID:27711253, PMID:30669930, PMID:25728673]. HSPB1 is also secreted from reactive astrocytes and taken up by neurons, where it non-cell-autonomously reduces pathological tau inclusions and attenuates neuroinflammation [PMID:38507480].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Early structural work established that specific domains contribute differentially to chaperone activity: the C-terminal extension is required for protection against reductive but not thermal unfolding, while HSPB1 participates in a native chaperone complex with Hsp110 and Hsc70, positioning it within the broader HSP70 disaggregation machinery.\",\n      \"evidence\": \"NMR/CD/AUC with C-terminal deletion mutant; Co-IP and in vitro reconstitution with Hsp110/Hsc70\",\n      \"pmids\": [\"10727931\", \"10631312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No atomic structure of full-length HSPB1 oligomer available\",\n        \"Stoichiometry and dynamics of the Hsp110/Hsc70/Hsp25 complex not resolved\",\n        \"How the C-terminal extension differentially contributes to substrate-specific chaperoning is unclear\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The upstream kinase cascades controlling HSPB1 oligomer dissociation were defined: p38 MAPK→MK2/3 and PKC independently phosphorylate HSPB1 to drive stress-induced oligomer disassembly, establishing the phosphorylation–oligomerization axis as the primary regulatory switch.\",\n      \"evidence\": \"Sucrose gradient fractionation with SB203580, PKC inhibitors, and phorbol ester across multiple stress conditions\",\n      \"pmids\": [\"11525238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative contributions of MK2 versus PKC to different stress types not quantified\",\n        \"In vivo phosphorylation kinetics and site ordering not established at this stage\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Phosphorylated HSPB1 was shown to associate specifically with F-actin and stabilize actin filaments against disruption, establishing a direct link between HSPB1 phosphorylation and cytoskeletal regulation beyond chaperoning.\",\n      \"evidence\": \"Triton X-100 fractionation and immunofluorescence in heat-stressed H9c2 myoblasts with phosphorylation-blocking drugs\",\n      \"pmids\": [\"12380682\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether HSPB1 binds F-actin directly or through adaptor proteins not resolved\",\n        \"Structural basis of phospho-HSPB1/F-actin interaction unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"HSPB1 was found to act as more than a holdase—it actively promotes ubiquitin-proteasomal degradation of specific client proteins, as shown by phosphorylated HSPB1 binding acetylated GATA-1 in the nucleus and directing its ubiquitination during erythroid differentiation.\",\n      \"evidence\": \"Reciprocal Co-IP, ubiquitination assay, siRNA in K562 and CD34+ erythroid cells\",\n      \"pmids\": [\"20410505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the E3 ligase mediating GATA-1 ubiquitination downstream of HSPB1 unknown\",\n        \"Whether nuclear HSPB1 chaperone-to-degradation triage is generalizable beyond GATA-1 not tested\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"EPR spin-labeling revealed that the N-terminal domain (NTD) is buried in the oligomer and becomes exposed upon dissociation to dimers, directly mediating substrate binding—resolving which structural element is the primary client-recognition site.\",\n      \"evidence\": \"Systematic cysteine mutagenesis with EPR and T4 lysozyme binding assays\",\n      \"pmids\": [\"22264079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic-resolution structure of NTD–substrate complex not available\",\n        \"Contribution of individual NTD residues to client selectivity untested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Phosphomimetic studies at S15/S78/S82 quantitatively linked site-specific phosphorylation to oligomer destabilization and enhanced chaperone activity against both amorphous and fibrillar aggregation, identifying the dimer as the primary chaperone-active species.\",\n      \"evidence\": \"Mass spectrometry of oligomeric distributions, phosphomimetic mutants, in vitro aggregation assays\",\n      \"pmids\": [\"25699602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the dimer or monomer is more relevant in vivo under different stress conditions remains debated\",\n        \"Quantitative relationship between phosphorylation stoichiometry and oligomer size in living cells not measured\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"HSPB1 was established as a negative regulator of ferroptosis: erastin induces HSF1-dependent HSPB1 transcription, and PKC-mediated HSPB1 phosphorylation suppresses iron-dependent lipid ROS accumulation, revealing a non-chaperoning cytoprotective role.\",\n      \"evidence\": \"siRNA/overexpression, PKC inhibition, lipid ROS measurement, xenograft mouse models\",\n      \"pmids\": [\"25728673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct molecular target through which HSPB1 modulates labile iron pool not identified\",\n        \"Whether ferroptosis suppression requires chaperone activity or is a distinct function unknown\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"HSPB1 was shown to regulate the Hippo pathway by promoting proteasomal degradation of ubiquitinated MST1, reducing LATS1 phosphorylation and increasing nuclear YAP activity—extending its client-to-degradation role to oncogenic signaling.\",\n      \"evidence\": \"Gain/loss-of-function in multiple cancer cell lines with proteasome inhibition\",\n      \"pmids\": [\"27555231\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"E3 ligase mediating MST1 ubiquitination in complex with HSPB1 not identified\",\n        \"Single-lab study; independent replication needed\",\n        \"Whether HSPB1 binds MST1 directly or as part of a larger complex not resolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NMR revealed that redox-generated HSPB1 monomers undergo partial unfolding of the β-strand dimer interface, producing highly active chaperone species, and that neuropathy-causing mutations cluster precisely in this dynamic region—connecting structural dynamics to disease.\",\n      \"evidence\": \"High-pressure and relaxation dispersion NMR with in vitro chaperone assays\",\n      \"pmids\": [\"30842409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How monomer dynamics change upon substrate engagement not characterized\",\n        \"Whether redox-driven monomerization occurs in neuronal cells in vivo not demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"HSPB1 was found to interact with the autophagy receptor SQSTM1/p62 via its PB1 domain, promoting autophagosome formation; neuropathy mutations impair this interaction and reduce autophagic flux, establishing a direct role in selective autophagy.\",\n      \"evidence\": \"LC-MS/MS interactome, Co-IP, HSPB1 KO rescue, patient-derived motor neurons\",\n      \"pmids\": [\"30669930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether HSPB1 acts as a co-receptor for ubiquitinated cargo or facilitates p62 phase separation unknown\",\n        \"Contribution of autophagy defect versus chaperone defect to neuropathy phenotype not disentangled\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The intramolecular auto-inhibition mechanism was resolved: the ACD binding groove sequesters the NTR, and mutations releasing this interaction enhance chaperone activity toward tau, explaining how oligomer disassembly activates substrate binding.\",\n      \"evidence\": \"In vitro chaperone assays and mutagenesis of ACD groove and NTR with tau substrate\",\n      \"pmids\": [\"31974309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the ACD-NTR auto-inhibition applies to all substrates or is tau-specific not tested\",\n        \"No high-resolution structure of the auto-inhibited state\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Co-aggregation was identified as the mechanism by which HSPB1 facilitates downstream refolding: HSPB1 co-aggregates with denatured substrates to produce smaller, more regular aggregates that are more efficiently disaggregated by HSP70, and homo-oligomerization is dispensable for this activity.\",\n      \"evidence\": \"In vitro reconstitution of co-aggregation and HSP70-led disaggregation with luciferase and LDH\",\n      \"pmids\": [\"34429462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether co-aggregation occurs in vivo and its quantitative contribution to cellular proteostasis unknown\",\n        \"How HSPB1 is released from co-aggregates after HSP70 action not characterized\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"HSPB1 was shown to be secreted from reactive astrocytes and taken up by neurons, where it non-cell-autonomously reduces tau inclusions and neuroinflammation, extending its function beyond intracellular chaperoning to intercellular proteostasis.\",\n      \"evidence\": \"Human AD brain immunohistochemistry, astrocyte conditioned media, neuronal uptake and tau inclusion assays\",\n      \"pmids\": [\"38507480\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Secretion mechanism (conventional vs. unconventional) not determined\",\n        \"Receptor or uptake mechanism in neurons unknown\",\n        \"Whether secreted HSPB1 retains chaperone activity extracellularly not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity of the molecular targets through which HSPB1 modulates labile iron to suppress ferroptosis; whether the chaperone, cytoskeletal, and ferroptosis functions are separable in vivo; the structural basis of NTR–substrate interactions at atomic resolution; and the mechanism of HSPB1 secretion and neuronal uptake.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No atomic-resolution structure of full-length HSPB1 in complex with a client\",\n        \"Iron-metabolic target in ferroptosis pathway unidentified\",\n        \"Secretion pathway and extracellular receptor unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [1, 2, 3, 4, 5, 6]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [20, 23, 25]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 10, 11, 29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 4, 7, 20]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [20, 23, 25]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [16, 27, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 1, 7, 22]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 10, 11, 30, 31]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 29, 32]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [13, 24, 34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 23, 26, 28]}\n    ],\n    \"complexes\": [\n      \"Hsp110/Hsc70/Hsp25 chaperone complex\"\n    ],\n    \"partners\": [\n      \"MAPKAPK2\",\n      \"SQSTM1\",\n      \"HSPH1\",\n      \"HSPA8\",\n      \"GATA1\",\n      \"SIRT1\",\n      \"SMURF2\",\n      \"SIRT2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HSPB1 (Hsp27) is an ATP-independent small heat shock protein that functions as a molecular chaperone, anti-apoptotic factor, and cytoskeletal regulator, with its diverse activities controlled by phosphorylation-dependent oligomeric dynamics. It forms large (~24-mer) oligomers that dissociate to chaperone-active dimers upon phosphorylation at Ser15, Ser78, and Ser82 by MAPKAP kinase-2 (downstream of p38 MAPK) or protein kinase C; the N-terminal domain encodes the oligomer–dimer equilibrium determinants and is essential for substrate engagement, while the alpha-crystallin domain harbors a client-binding groove also used for autoinhibitory intramolecular contacts [PMID:1332886, PMID:10383393, PMID:25699602, PMID:31974309, PMID:22264079]. Phosphorylated HSPB1 stabilizes actin filaments, promotes BMP-2-induced cell migration, co-aggregates with unfolded substrates to facilitate Hsp70-mediated disaggregation, negatively regulates ferroptosis by suppressing iron-mediated lipid ROS, sequesters cytochrome c to block Apaf-1/caspase-9-dependent apoptosis, and directs client proteins (GATA-1, MST1) to ubiquitin–proteasomal degradation [PMID:7799959, PMID:10980706, PMID:34429462, PMID:25728673, PMID:20410505, PMID:27555231]. Mutations in the alpha-crystallin domain cause axonal Charcot-Marie-Tooth disease type 2F (CMT2F) and distal hereditary motor neuropathy by disrupting oligomer dynamics, impairing SQSTM1/p62-dependent autophagy, and increasing Cdk5-mediated neurofilament hyperphosphorylation that compromises axonal transport [PMID:15122254, PMID:23728742, PMID:30669930].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Identifying the upstream kinase for stress-induced HSPB1 phosphorylation resolved how extracellular signals control HSPB1 post-translational modification: MAPKAP kinase-2 phosphorylates Ser15, Ser78, and Ser82 downstream of p38 MAPK.\",\n      \"evidence\": \"In vitro kinase assay with co-purification and peptide mapping of phosphorylation sites\",\n      \"pmids\": [\"1332886\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other kinases independently phosphorylate HSPB1 in vivo was not addressed\", \"Stoichiometry and kinetics of phosphorylation at each site in living cells remained unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing HSPB1 as an ATP-independent molecular chaperone defined its core biochemical activity: preventing aggregation of thermally or chemically unfolding proteins and promoting their refolding.\",\n      \"evidence\": \"Reconstituted in vitro chaperone assays with purified HSPB1 and multiple model substrates (citrate synthase, alpha-glucosidase)\",\n      \"pmids\": [\"8093612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of substrate recognition was undefined\", \"Whether chaperone activity was regulated in vivo was unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Linking phosphorylation to actin stabilization revealed a non-chaperone effector function: phosphorylation-dependent oligomer dissociation is required for HSPB1 to protect microfilaments from heat- and drug-induced disruption.\",\n      \"evidence\": \"Wild-type vs. non-phosphorylatable (pm3) mutant HSPB1 stable transfection in hamster cells with cytochalasin and heat shock\",\n      \"pmids\": [\"7799959\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between HSPB1 and F-actin was not mapped\", \"Whether actin stabilization and chaperone holdase activity share the same binding surface was unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Phosphomimetic dissection showed that progressive phosphorylation shifts HSPB1 from large oligomers to tetramers/dimers; this oligomeric transition inversely controls thermal chaperone activity and oxidative stress protection, establishing the oligomer–activity paradigm.\",\n      \"evidence\": \"Phosphomimetic mutagenesis (S15D/S78D/S82D), gel filtration, thermal aggregation assay, cell survival in L929 and 13.S.1.24 cells\",\n      \"pmids\": [\"10383393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether smaller species are more active toward all substrates or only some was untested\", \"Structural basis of substrate binding by dimers vs. oligomers was unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that HSPB1 sequesters cytochrome c to block Apaf-1/caspase-9 assembly provided a direct molecular mechanism for its anti-apoptotic role, independent of its chaperone or actin functions.\",\n      \"evidence\": \"Cell-free caspase activation assay and co-immunoprecipitation of HSPB1 with cytochrome c\",\n      \"pmids\": [\"10980706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding stoichiometry and affinity of HSPB1–cytochrome c interaction were not determined\", \"Whether phosphorylation state affects cytochrome c binding was unexplored\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Structural analysis of the C-terminal extension revealed substrate-selective roles: it is required for chaperone activity toward some but not all clients, and it remains flexible during client interaction, contributing to accessible hydrophobic surface.\",\n      \"evidence\": \"NMR, analytical ultracentrifugation, electron microscopy, and dual-substrate chaperone assays on Hsp25 C-terminal deletion mutants\",\n      \"pmids\": [\"10727931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which clients require the C-terminal extension and why was not systematically catalogued\", \"Role of C-terminal extension in oligomer formation was not fully resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of HSPB1 mutations as the genetic cause of CMT2F and distal hereditary motor neuropathy established the gene's essential role in axonal integrity; mutant HSPB1 disrupted neurofilament assembly and reduced neuronal viability.\",\n      \"evidence\": \"Genetic linkage and mutation screening in CMT2F/dHMN families; transfection of mutant HSPB1 in neuronal cells with neurofilament assembly assay\",\n      \"pmids\": [\"15122254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mutations act via loss-of-function, gain-of-toxic-function, or both was unresolved\", \"The precise structural consequences of mutations on oligomer dynamics were unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that phosphorylated HSPB1 translocates to the nucleus, binds acetylated GATA-1, and promotes its ubiquitination and proteasomal degradation revealed a novel mechanism by which HSPB1 controls transcription factor turnover during erythroid differentiation.\",\n      \"evidence\": \"siRNA knockdown, reciprocal co-IP of HSPB1 with GATA-1, nuclear fractionation, ubiquitination assay in K562 and CD34+ erythroid differentiation models\",\n      \"pmids\": [\"20410505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ligase recruited by HSPB1 for GATA-1 ubiquitination was not identified\", \"Whether HSPB1 promotes degradation of other transcription factors via the same mechanism was untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"EPR spectroscopy of systematically spin-labeled HSPB1 mapped the N-terminal domain as the determinant of the oligomer–dimer equilibrium and showed that substrate binding buries N-terminal residues, structurally resolving how client engagement is coupled to oligomeric state.\",\n      \"evidence\": \"Systematic cysteine mutagenesis with EPR spectroscopy, sucrose gradient sedimentation, substrate (T4 lysozyme) binding assays\",\n      \"pmids\": [\"22264079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of HSPB1 oligomer with bound substrate was lacking\", \"How the N-terminal domain distinguishes different clients was not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"CMT-causing HSPB1 mutations were shown to increase Cdk5-mediated neurofilament hyperphosphorylation and impair kinesin-dependent anterograde transport, with Cdk5 inhibition rescuing the transport defect—providing a druggable pathomechanistic axis.\",\n      \"evidence\": \"Stable transduction of WT and mutant HSPB1 in neuronal cells, axonal transport assay, Cdk5 inhibition, co-IP of neurofilament with kinesin\",\n      \"pmids\": [\"23728742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HSPB1 mutations activate Cdk5 was not determined\", \"Whether Cdk5 inhibition rescues axonal degeneration in vivo was untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Native mass spectrometry resolved the full phosphorylation-dependent oligomeric landscape, demonstrating that triple-phosphomimetic HSPB1 exists predominantly as dimers with enhanced chaperone activity against both amorphous and fibrillar aggregation—reconciling earlier conflicting reports about phosphorylation and activity.\",\n      \"evidence\": \"Native MS of WT and progressive phosphomimetic mutants, chaperone assays against amorphous and amyloid aggregation\",\n      \"pmids\": [\"25699602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether dimers are the sole chaperone-active species in cells was not confirmed in vivo\", \"Phosphorylation heterogeneity within oligomers in native tissues remained unmeasured\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"HSPB1 was established as a negative regulator of ferroptosis: PKC-mediated phosphorylation of HSPB1 suppresses iron-dependent lipid ROS accumulation, defining a new cell death modality controlled by this chaperone.\",\n      \"evidence\": \"siRNA knockdown and overexpression of HSPB1, PKC inhibition, lipid ROS and iron measurements, xenograft model\",\n      \"pmids\": [\"25728673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target through which HSPB1 controls iron metabolism was not identified\", \"Whether chaperone activity or a distinct function mediates ferroptosis suppression was unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"HSPB1 was shown to promote proteasomal degradation of MST1, the core Hippo pathway kinase, thereby activating YAP—extending its client-degradation function beyond GATA-1 to a key tumor-suppressor pathway.\",\n      \"evidence\": \"Gain/loss-of-function in prostate, breast, and lung cancer cells, co-IP, proteasome inhibition rescue, phospho-YAP immunofluorescence\",\n      \"pmids\": [\"27555231\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HSPB1 directly binds MST1 or acts through an adaptor was not resolved\", \"Ubiquitin ligase identity for MST1 degradation was not determined\", \"Independent replication in non-cancer contexts is lacking\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Relaxation dispersion NMR revealed that HSPB1 monomers (generated by disulfide reduction) are highly chaperone-active but conformationally unstable, with partial unfolding in the alpha-crystallin domain dimerization interface—the same region where neuropathy mutations cluster—linking structural dynamics to both function and disease.\",\n      \"evidence\": \"Relaxation dispersion and high-pressure NMR, redox manipulation, in vitro chaperone assays\",\n      \"pmids\": [\"30842409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether monomer-driven chaperone activity is physiologically relevant given rapid dimerization tendency was unclear\", \"Redox regulation of HSPB1 oligomeric state in vivo was not quantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"HSPB1 was found to interact with SQSTM1/p62 via its PB1 domain, and this interaction is required for p62 body formation and autophagosome biogenesis; CMT-linked mutations impair this interaction, directly connecting HSPB1-dependent autophagy to neuropathic disease.\",\n      \"evidence\": \"LC-MS/MS interactome, co-IP, domain mapping, HSPB1-KO rescue experiments, patient-derived motor neurons\",\n      \"pmids\": [\"30669930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether autophagy impairment is the primary driver of CMT2F or acts in concert with neurofilament defects was unresolved\", \"Structural basis of HSPB1–p62 PB1 domain interaction was not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NMR and mutagenesis showed that the tau-binding groove on the alpha-crystallin domain is autoinhibited by HSPB1's own N-terminal region; disrupting these intramolecular contacts greatly enhances chaperone activity toward tau, establishing a mechanism for regulated substrate access.\",\n      \"evidence\": \"In vitro chaperone assays with tau, NMR, ACD–NTR interaction-disrupting mutations, domain deletions\",\n      \"pmids\": [\"31974309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether phosphorylation at the N-terminal domain releases autoinhibition in the same manner was not directly tested\", \"In vivo relevance for tau pathology in neurodegenerative disease was not demonstrated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"HSPB1 was shown to co-aggregate with unfolded substrates, reshaping aggregates into forms efficiently disaggregated by HSP70—redefining HSPB1's holdase function as an active co-aggregation and disaggregation-facilitating mechanism rather than passive aggregation prevention.\",\n      \"evidence\": \"Reconstituted in vitro co-aggregation and disaggregation assays with oligomerization-deficient mutants, substrate refolding measurement\",\n      \"pmids\": [\"34429462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether co-aggregation occurs and is functionally relevant in cells was not demonstrated\", \"Structural organization of HSPB1 within co-aggregates was not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstration that reactive astrocytes secrete HSPB1 and that neighboring neurons take it up—reducing pathological tau inclusions—established a non-cell-autonomous chaperone mechanism relevant to neurodegeneration.\",\n      \"evidence\": \"Conditioned medium transfer, live imaging of HSPB1 uptake, immunofluorescence of human AD brain, siRNA knockdown, tau inclusion assay\",\n      \"pmids\": [\"38507480\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Secretion mechanism (conventional vs. unconventional) is undefined\", \"Quantitative contribution of extracellular HSPB1 relative to cell-autonomous pools in neuroprotection is unknown\", \"Replication across independent labs is needed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how phosphorylation heterogeneity within native HSPB1 oligomers controls substrate selectivity in vivo; the identity of E3 ubiquitin ligases recruited by HSPB1 for client degradation; whether gain-of-toxic-function versus loss-of-chaperone-function underlies CMT2F; and the mechanistic basis by which HSPB1 modulates iron metabolism to suppress ferroptosis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of a full-length HSPB1 oligomer with bound client\", \"Relative contribution of autophagy impairment vs. neurofilament transport defects in CMT2F pathogenesis\", \"Direct ferroptosis-relevant molecular target of HSPB1 is unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [1, 3, 5, 24, 31, 34, 35]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2, 13, 16, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 25, 28, 32]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 3, 4, 24, 35]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [2, 13, 16, 19]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [13, 18]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [22, 39]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 1, 3, 7, 12, 25, 36]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 25, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 19, 28, 30]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [18, 28, 35]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [32]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"complexes\": [\n      \"Hsp25/Hsp70/Hsp110 chaperone complex\"\n    ],\n    \"partners\": [\n      \"MAPKAPK2\",\n      \"SQSTM1\",\n      \"GATA1\",\n      \"SIRT1\",\n      \"MST1\",\n      \"TLR3\",\n      \"TGFB1I1\",\n      \"G6PD\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}